<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Med</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Med</journal-id><journal-id journal-id-type="publisher-id">pmed</journal-id><journal-id journal-id-type="publisher-id">plme</journal-id><journal-id journal-id-type="pmc">plosmed</journal-id><journal-title-group><journal-title>PLoS Medicine</journal-title></journal-title-group><issn pub-type="ppub">1549-1277</issn><issn pub-type="epub">1549-1676</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">17341128</article-id><article-id pub-id-type="pmc">1808482</article-id><article-id pub-id-type="doi">10.1371/journal.pmed.0040076</article-id><article-id pub-id-type="publisher-id">06-PLME-RA-0483R2</article-id><article-id pub-id-type="sici">plme-04-03-02</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biochemistry</subject><subject>Diabetes and Endocrinology</subject><subject>Geriatrics</subject><subject>Molecular Biology</subject><subject>Nutrition</subject><subject>Physiology</subject></subj-group><subj-group subj-group-type="System Taxonomy"><subject>Nutrition and Metabolism</subject><subject>Endocrinology</subject><subject>Geriatric Medicine</subject></subj-group></article-categories><title-group><article-title>Calorie Restriction Increases Muscle Mitochondrial Biogenesis in Healthy Humans</article-title><alt-title alt-title-type="running-head">Caloric Restriction and Mitochondria</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Civitarese</surname><given-names>Anthony E</given-names></name><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Carling</surname><given-names>Stacy</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Heilbronn</surname><given-names>Leonie K</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Hulver</surname><given-names>Mathew H</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Ukropcova</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Deutsch</surname><given-names>Walter A</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Steven R</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Ravussin</surname><given-names>Eric</given-names></name><role>for the CALERIE Pennington Team</role><xref ref-type="aff" rid="aff1"></xref></contrib></contrib-group><aff id="aff1">Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States of America</aff><contrib-group><contrib contrib-type="editor"><name><surname>Barzilai</surname><given-names>Nir</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"></xref></contrib></contrib-group><aff id="edit1">Albert Einstein College of Medicine, United States of America</aff><author-notes><corresp id="cor1">* To whom correspondence should be addressed. E-mail: <email>CivitaAE@pbrc.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2007</year></pub-date><pub-date pub-type="epub"><day>6</day><month>3</month><year>2007</year></pub-date><volume>4</volume><issue>3</issue><elocation-id>e76</elocation-id><history><date date-type="received"><day>27</day><month>6</month><year>2006</year></date><date date-type="accepted"><day>4</day><month>1</month><year>2007</year></date></history><permissions><copyright-statement> © 2007 Civitarese et al.</copyright-statement><copyright-year>2007</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="4639" xml_f="4649" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="4660" xml_f="4906" txt_i="22" txt_f="268">Caloric restriction without malnutrition extends life span in a range of organisms including insects and mammals and lowers free radical production by the mitochondria. However, the mechanism responsible for this adaptation are poorly understood.</offsets></p></sec><sec id="st2"><title><offsets xml_i="4937" xml_f="4957" txt_i="270" txt_f="290">Methods and Findings</offsets></title><p><offsets xml_i="4968" xml_f="5192" txt_i="291" txt_f="515">The current study was undertaken to examine muscle mitochondrial bioenergetics in response to caloric restriction alone or in combination with exercise in 36 young (36.8 ± 1.0 y), overweight (body mass index, 27.8 ± 0.7 kg/m</offsets><sup><offsets xml_i="5197" xml_f="5198" txt_i="515" txt_f="516">2</offsets></sup><offsets xml_i="5204" xml_f="5628" txt_i="516" txt_f="940">) individuals randomized into one of three groups for a 6-mo intervention: Control, 100% of energy requirements; CR, 25% caloric restriction; and CREX, caloric restriction with exercise (CREX), 12.5% CR + 12.5% increased energy expenditure (EE). In the controls, 24-h EE was unchanged, but in CR and CREX it was significantly reduced from baseline even after adjustment for the loss of metabolic mass (CR, −135 ± 42 kcal/d, </offsets><italic><offsets xml_i="5636" xml_f="5637" txt_i="940" txt_f="941">p</offsets></italic><offsets xml_i="5646" xml_f="5683" txt_i="941" txt_f="978"> = 0.002 and CREX, −117 ± 52 kcal/d, </offsets><italic><offsets xml_i="5691" xml_f="5692" txt_i="978" txt_f="979">p</offsets></italic><offsets xml_i="5701" xml_f="5890" txt_i="979" txt_f="1168"> = 0.008). Participants in the CR and CREX groups had increased expression of genes encoding proteins involved in mitochondrial function such as PPARGC1A, TFAM, eNOS, SIRT1, and PARL (all, </offsets><italic><offsets xml_i="5898" xml_f="5899" txt_i="1168" txt_f="1169">p</offsets></italic><offsets xml_i="5908" xml_f="5999" txt_i="1169" txt_f="1257"> &lt; 0.05). In parallel, mitochondrial DNA content increased by 35% ± 5% in the CR group (</offsets><italic><offsets xml_i="6007" xml_f="6008" txt_i="1257" txt_f="1258">p</offsets></italic><offsets xml_i="6017" xml_f="6059" txt_i="1258" txt_f="1300"> = 0.005) and 21% ± 4% in the CREX group (</offsets><italic><offsets xml_i="6067" xml_f="6068" txt_i="1300" txt_f="1301">p</offsets></italic><offsets xml_i="6077" xml_f="6448" txt_i="1301" txt_f="1669"> &lt; 0.004), with no change in the control group (2% ± 2%). However, the activity of key mitochondrial enzymes of the TCA (tricarboxylic acid) cycle (citrate synthase), beta-oxidation (beta-hydroxyacyl-CoA dehydrogenase), and electron transport chain (cytochrome C oxidase II) was unchanged. DNA damage was reduced from baseline in the CR (−0.56 ± 0.11 arbitrary units, </offsets><italic><offsets xml_i="6456" xml_f="6457" txt_i="1669" txt_f="1670">p</offsets></italic><offsets xml_i="6466" xml_f="6516" txt_i="1670" txt_f="1720"> = 0.003) and CREX (−0.45 ± 0.12 arbitrary units, </offsets><italic><offsets xml_i="6524" xml_f="6525" txt_i="1720" txt_f="1721">p</offsets></italic><offsets xml_i="6534" xml_f="6809" txt_i="1721" txt_f="1996"> = 0.011), but not in the controls. In primary cultures of human myotubes, a nitric oxide donor (mimicking eNOS signaling) induced mitochondrial biogenesis but failed to induce SIRT1 protein expression, suggesting that additional factors may regulate SIRT1 content during CR.</offsets></p></sec><sec id="st3"><title><offsets xml_i="6840" xml_f="6851" txt_i="1998" txt_f="2009">Conclusions</offsets></title><p><offsets xml_i="6862" xml_f="7083" txt_i="2010" txt_f="2231">The observed increase in muscle mitochondrial DNA in association with a decrease in whole body oxygen consumption and DNA damage suggests that caloric restriction improves mitochondrial function in young non-obese adults.</offsets></p></sec></abstract><abstract abstract-type="toc"><p><offsets xml_i="7137" xml_f="7323" txt_i="2244" txt_f="2430">Anthony Civitarese and colleagues observed an increase in mitochondrial DNA in muscle and a decrease in whole body oxygen consumption in healthy adults who underwent caloric restriction.</offsets></p></abstract><abstract abstract-type="editor"><title><offsets xml_i="7378" xml_f="7394" txt_i="2442" txt_f="2458">Editors' Summary</offsets></title><sec id="sb1a"><title><offsets xml_i="7424" xml_f="7435" txt_i="2459" txt_f="2470">Background.</offsets></title><p><offsets xml_i="7446" xml_f="8847" txt_i="2471" txt_f="3872">Life expectancy (the average life span) greatly increased during the 20th century in most countries, largely due to improved hygiene, nutrition, and health care. One possible approach to further increase human life span is “caloric restriction.” A calorie-restricted diet provides all the nutrients necessary for a healthy life but minimizes the energy (calories) supplied in the diet. This type of diet increases the life span of mice and delays the onset of age-related chronic diseases such as heart disease and stroke. There are also hints that people who eat a calorie-restricted diet might live longer than those who overeat. People living in Okinawa, Japan, have a lower energy intake than the rest of the Japanese population and an extremely long life span. In addition, calorie-restricted diets beneficially affect several biomarkers of aging, including decreased insulin sensitivity (a precursor to diabetes). But how might caloric restriction slow aging? A major factor in the age-related decline of bodily functions is the accumulation of “oxidative damage” in the body's proteins, fats, and DNA. Oxidants—in particular, chemicals called “free radicals”—are produced when food is converted to energy by cellular structures called mitochondria. One theory for how caloric restriction slows aging is that it lowers free-radical production by inducing the formation of efficient mitochondria.</offsets></p></sec><sec id="sb1b"><title><offsets xml_i="8879" xml_f="8903" txt_i="3874" txt_f="3898">Why Was This Study Done?</offsets></title><p><offsets xml_i="8914" xml_f="9783" txt_i="3899" txt_f="4768">Despite hints that caloric restriction might have similar effects in people as in rodents, there have been few well-controlled studies on the effect of good quality calorie-reduced diets in healthy people. It is also unknown whether an energy deficit produced by increasing physical activity while eating the same amount of food has the same effects as caloric restriction. Finally, it is unclear how caloric restriction alters mitochondrial function. The Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) organization is investigating the effect of caloric restriction interventions on physiology, body composition, and risk factors for age-related diseases. In this study, the researchers have tested the hypothesis that short-term caloric deficit (with or without exercise) increases the efficiency of mitochondria in human muscle.</offsets></p></sec><sec id="sb1c"><title><offsets xml_i="9815" xml_f="9852" txt_i="4770" txt_f="4807">What Did the Researchers Do and Find?</offsets></title><p><offsets xml_i="9863" xml_f="10777" txt_i="4808" txt_f="5722">The researchers enrolled 36 healthy overweight but non-obese young people into their study. One-third of them received 100% of their energy requirements in their diet; the caloric restriction (CR) group had their calorie intake reduced by 25%; and the caloric restriction plus exercise (CREX) group had their calorie intake reduced by 12.5% and their energy expenditure increased by 12.5%. The researchers found that a 25% caloric deficit for six months, achieved by diet alone or by diet plus exercise, decreased 24-hour whole body energy expenditure (i.e., overall calories burned for body function), which suggests improved mitochondrial function. Their analysis of genes involved in mitochondria formation indicated that CR and CREX both increased the number of mitochondria in skeletal muscle. Both interventions also reduced the amount of DNA damage—a marker of oxidative stress—in the participants' muscles.</offsets></p></sec><sec id="sb1d"><title><offsets xml_i="10809" xml_f="10837" txt_i="5724" txt_f="5752">What Do These Findings Mean?</offsets></title><p><offsets xml_i="10848" xml_f="11718" txt_i="5753" txt_f="6623">These results indicate that a short-term caloric deficit, whether achieved by diet or by diet plus exercise, induces the formation of “efficient mitochondria” in people just as in rodents. The induction of these efficient mitochondria in turn reduces oxidative damage in skeletal muscles. Consequently, this adaptive response to caloric restriction might have the potential to slow aging and increase longevity in humans as in other animals. However, this six-month study obviously provides no direct evidence for this, and, by analogy with studies in rodents, an increase in longevity might require lifelong caloric restriction. The results here suggest that even short-term caloric restriction can produce beneficial physiological changes, but more research is necessary before it becomes clear whether caloric restriction should be recommended to healthy individuals.</offsets></p></sec><sec id="sb1e"><title><offsets xml_i="11750" xml_f="11773" txt_i="6625" txt_f="6648">Additional Information.</offsets></title><p><offsets xml_i="11784" xml_f="11856" txt_i="6649" txt_f="6721">Please access these Web sites via the online version of this summary at </offsets><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0040076"><offsets xml_i="11946" xml_f="11992" txt_i="6721" txt_f="6767">http://dx.doi.org/10.1371/journal.pmed.0040076</offsets></ext-link><offsets xml_i="12003" xml_f="12004" txt_i="6767" txt_f="6768">.</offsets></p><list list-type="bullet"><list-item><p><offsets xml_i="12047" xml_f="12051" txt_i="6769" txt_f="6773">The </offsets><ext-link ext-link-type="uri" xlink:href="http://calerie.dcri.duke.edu/sites/lsu/index.html"><offsets xml_i="12144" xml_f="12228" txt_i="6773" txt_f="6857">CALERIE (Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy)</offsets></ext-link><offsets xml_i="12239" xml_f="12305" txt_i="6857" txt_f="6923"> Web site contains information on the study and how to participate</offsets></p></list-item><list-item><p><offsets xml_i="12335" xml_f="12336" txt_i="6924" txt_f="6925">
</offsets><ext-link ext-link-type="uri" xlink:href="http://websites.afar.org/site/PageServer?pagename=IA_homepage"><offsets xml_i="12441" xml_f="12479" txt_i="6925" txt_f="6963">American Federation for Aging Research</offsets></ext-link><offsets xml_i="12490" xml_f="12582" txt_i="6963" txt_f="7055"> includes information on aging with pages on the biology of aging and on caloric restriction</offsets></p></list-item><list-item><p><offsets xml_i="12612" xml_f="12613" txt_i="7056" txt_f="7057">
</offsets><ext-link ext-link-type="uri" xlink:href="http://www.okinawaprogram.com/"><offsets xml_i="12687" xml_f="12716" txt_i="7057" txt_f="7086">The Okinawa Centenarian Study</offsets></ext-link><offsets xml_i="12727" xml_f="12802" txt_i="7086" txt_f="7161"> is a population-based study on long-lived elderly people in Okinawa, Japan</offsets></p></list-item><list-item><p><offsets xml_i="12832" xml_f="12861" txt_i="7162" txt_f="7191">US Government information on </offsets><ext-link ext-link-type="uri" xlink:href="http://www.nutrition.gov/"><offsets xml_i="12930" xml_f="12939" txt_i="7191" txt_f="7200">nutrition</offsets></ext-link><offsets xml_i="12950" xml_f="12951" txt_i="7200" txt_f="7201">
</offsets></p></list-item><list-item><p><offsets xml_i="12981" xml_f="12982" txt_i="7202" txt_f="7203">
</offsets><ext-link ext-link-type="uri" xlink:href="http://www.nlm.nih.gov/medlineplus/ency/article/002457.htm"><offsets xml_i="13084" xml_f="13095" txt_i="7203" txt_f="7214">MedlinePlus</offsets></ext-link><offsets xml_i="13106" xml_f="13146" txt_i="7214" txt_f="7254"> encyclopedia pages on diet and calories</offsets></p></list-item><list-item><p><offsets xml_i="13176" xml_f="13177" txt_i="7255" txt_f="7256">
</offsets><ext-link ext-link-type="uri" xlink:href="http://www.calorierestriction.org/"><offsets xml_i="13255" xml_f="13286" txt_i="7256" txt_f="7287">The Calorie Restriction Society</offsets></ext-link><offsets xml_i="13297" xml_f="13386" txt_i="7287" txt_f="7376">, a nonprofit organization that provides information on life span and caloric restriction</offsets></p></list-item><list-item><p><offsets xml_i="13416" xml_f="13435" txt_i="7377" txt_f="7396">Wikipedia pages on </offsets><ext-link ext-link-type="uri" xlink:href="http://en.wikipedia.org/wiki/Calorie_restriction"><offsets xml_i="13527" xml_f="13546" txt_i="7396" txt_f="7415">calorie restriction</offsets></ext-link><offsets xml_i="13557" xml_f="13565" txt_i="7415" txt_f="7423"> and on </offsets><ext-link ext-link-type="uri" xlink:href="http://en.wikipedia.org/wiki/Mitochondrion"><offsets xml_i="13651" xml_f="13663" txt_i="7423" txt_f="7435">mitochondria</offsets></ext-link><offsets xml_i="13674" xml_f="13739" txt_i="7435" txt_f="7500"> (note: Wikipedia is an online encyclopedia that anyone can edit)</offsets></p></list-item></list></sec></abstract><counts><page-count count="10"></page-count></counts><custom-meta-group><custom-meta><meta-name>citation</meta-name><meta-value>Civitarese AE, Carling S, Heilbronn LK, Hulver MH, Ukropcova B, et al. (2007) Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med 4(3): e76. doi:<ext-link ext-link-type="doi" xlink:href="10.1371/journal.pmed.0040076">10.1371/journal.pmed.0040076</ext-link></meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title><offsets xml_i="14297" xml_f="14309" txt_i="7509" txt_f="7521">Introduction</offsets></title><p><offsets xml_i="14320" xml_f="14420" txt_i="7522" txt_f="7622">Caloric restriction delays the rate of aging in many species such as yeast, worms, flies, and mice [</offsets><xref rid="pmed-0040076-b001" ref-type="bibr"><offsets xml_i="14466" xml_f="14467" txt_i="7622" txt_f="7623">1</offsets></xref><offsets xml_i="14474" xml_f="14879" txt_i="7623" txt_f="8028">]. One theory is that caloric restriction reduces oxidative damage to proteins, lipids, and DNA, although the underlying mechanisms of this process are unclear. Cellular nutrient sensing systems seem to mediate many of the metabolic responses to caloric restriction, including the regulation of free radical production and oxidative stress. Mitochondria are the major consumers of cellular oxygen (~85%) [</offsets><xref rid="pmed-0040076-b002" ref-type="bibr"><offsets xml_i="14925" xml_f="14926" txt_i="8028" txt_f="8029">2</offsets></xref><offsets xml_i="14933" xml_f="15032" txt_i="8029" txt_f="8128">] and the predominant production site of free radicals, a by-product of oxidative phosphorylation [</offsets><xref rid="pmed-0040076-b003" ref-type="bibr"><offsets xml_i="15078" xml_f="15079" txt_i="8128" txt_f="8129">3</offsets></xref><offsets xml_i="15086" xml_f="15257" txt_i="8129" txt_f="8300">]. Studies in mammals have shown that caloric restriction reduces the generation of free radicals by mitochondria, in parallel to reductions in mitochondrial proton leak [</offsets><xref rid="pmed-0040076-b004" ref-type="bibr"><offsets xml_i="15303" xml_f="15304" txt_i="8300" txt_f="8301">4</offsets></xref><offsets xml_i="15311" xml_f="15312" txt_i="8301" txt_f="8302">,</offsets><xref rid="pmed-0040076-b005" ref-type="bibr"><offsets xml_i="15358" xml_f="15359" txt_i="8302" txt_f="8303">5</offsets></xref><offsets xml_i="15366" xml_f="15387" txt_i="8303" txt_f="8324">] and whole-body EE [</offsets><xref rid="pmed-0040076-b004" ref-type="bibr"><offsets xml_i="15433" xml_f="15434" txt_i="8324" txt_f="8325">4</offsets></xref><offsets xml_i="15441" xml_f="15632" txt_i="8325" txt_f="8516">] (defined as oxidation or combustion of food and/or energy stores to meet the body's energy requirements). Paradoxically, caloric restriction induces mitochondrial proliferation in rodents [</offsets><xref rid="pmed-0040076-b006" ref-type="bibr"><offsets xml_i="15678" xml_f="15679" txt_i="8516" txt_f="8517">6</offsets></xref><offsets xml_i="15686" xml_f="15687" txt_i="8517" txt_f="8518">,</offsets><xref rid="pmed-0040076-b007" ref-type="bibr"><offsets xml_i="15733" xml_f="15734" txt_i="8518" txt_f="8519">7</offsets></xref><offsets xml_i="15741" xml_f="15763" txt_i="8519" txt_f="8541">], and either lowers [</offsets><xref rid="pmed-0040076-b008" ref-type="bibr"><offsets xml_i="15809" xml_f="15810" txt_i="8541" txt_f="8542">8</offsets></xref><offsets xml_i="15817" xml_f="15872" txt_i="8542" txt_f="8597">] or does not affect mitochondrial oxygen consumption [</offsets><xref rid="pmed-0040076-b006" ref-type="bibr"><offsets xml_i="15918" xml_f="15919" txt_i="8597" txt_f="8598">6</offsets></xref><offsets xml_i="15926" xml_f="16142" txt_i="8598" txt_f="8814">]. Taken together, these data suggest that caloric restriction improves whole body energy efficiency by inducing the biogenesis of mitochondria that utilize less oxygen and produce less reactive oxygen species (ROS).</offsets></p><p><offsets xml_i="16149" xml_f="16525" txt_i="8815" txt_f="9191">Most research on the transcriptional regulation of mitochondrial number and function focuses on downstream transcription factors such as nuclear respiratory factors (NRF) 1 and 2, and transcription factor A, mitochondrial (TFAM). These transcription factors coordinate the transcription of both the nuclear and the mitochondrial genes involved in mitochondrial bioenergetics [</offsets><xref rid="pmed-0040076-b009" ref-type="bibr"><offsets xml_i="16571" xml_f="16572" txt_i="9191" txt_f="9192">9</offsets></xref><offsets xml_i="16579" xml_f="16580" txt_i="9192" txt_f="9193">,</offsets><xref rid="pmed-0040076-b010" ref-type="bibr"><offsets xml_i="16626" xml_f="16628" txt_i="9193" txt_f="9195">10</offsets></xref><offsets xml_i="16635" xml_f="16642" txt_i="9195" txt_f="9202">]. The </offsets><italic><offsets xml_i="16650" xml_f="16713" txt_i="9202" txt_f="9265">peroxisome proliferator-activated receptor gamma coactivator 1α</offsets></italic><offsets xml_i="16722" xml_f="16724" txt_i="9265" txt_f="9267"> (</offsets><italic><offsets xml_i="16732" xml_f="16741" txt_i="9267" txt_f="9276">PPARGC1A)</offsets></italic><offsets xml_i="16750" xml_f="16768" txt_i="9276" txt_f="9294"> lies upstream of </offsets><italic><offsets xml_i="16776" xml_f="16780" txt_i="9294" txt_f="9298">NRF1</offsets></italic><offsets xml_i="16789" xml_f="16794" txt_i="9298" txt_f="9303"> and </offsets><italic><offsets xml_i="16802" xml_f="16807" txt_i="9303" txt_f="9308">TFAM,</offsets></italic><offsets xml_i="16816" xml_f="16981" txt_i="9308" txt_f="9473"> and the protein serves as a nutrient sensing system that increases mitochondrial biogenesis and shifts substrate utilization toward fat and away from carbohydrate [</offsets><xref rid="pmed-0040076-b011" ref-type="bibr"><offsets xml_i="17027" xml_f="17029" txt_i="9473" txt_f="9475">11</offsets></xref><offsets xml_i="17036" xml_f="17064" txt_i="9475" txt_f="9503">]. A molecular regulator of </offsets><italic><offsets xml_i="17072" xml_f="17080" txt_i="9503" txt_f="9511">PPARGC1A</offsets></italic><offsets xml_i="17089" xml_f="17216" txt_i="9511" txt_f="9638"> is Sir2, a nicotinamide adenine dinucleotide (NAD)-dependent deacetylase that prolongs life span in yeast when overexpressed [</offsets><xref rid="pmed-0040076-b012" ref-type="bibr"><offsets xml_i="17262" xml_f="17264" txt_i="9638" txt_f="9640">12</offsets></xref><offsets xml_i="17271" xml_f="17495" txt_i="9640" txt_f="9864">]. The mechanism through which Sir2 extends life span is unclear, although data show that Sir2-mediated deacetylation of modified lysine residues on histones, transcription factors, and other nuclear substrates is involved [</offsets><xref rid="pmed-0040076-b011" ref-type="bibr"><offsets xml_i="17541" xml_f="17543" txt_i="9864" txt_f="9866">11</offsets></xref><offsets xml_i="17550" xml_f="17551" txt_i="9866" txt_f="9867">,</offsets><xref rid="pmed-0040076-b013" ref-type="bibr"><offsets xml_i="17597" xml_f="17599" txt_i="9867" txt_f="9869">13</offsets></xref><offsets xml_i="17606" xml_f="17607" txt_i="9869" txt_f="9870">,</offsets><xref rid="pmed-0040076-b014" ref-type="bibr"><offsets xml_i="17653" xml_f="17655" txt_i="9870" txt_f="9872">14</offsets></xref><offsets xml_i="17662" xml_f="17752" txt_i="9872" txt_f="9962">]. The mammalian ortholog of Sir2, known as sirtuin 1 (SIRT1), deacetylates and activates </offsets><italic><offsets xml_i="17760" xml_f="17768" txt_i="9962" txt_f="9970">PPARGC1A</offsets></italic><offsets xml_i="17777" xml_f="17779" txt_i="9970" txt_f="9972"> [</offsets><xref rid="pmed-0040076-b011" ref-type="bibr"><offsets xml_i="17825" xml_f="17827" txt_i="9972" txt_f="9974">11</offsets></xref><offsets xml_i="17834" xml_f="17835" txt_i="9974" txt_f="9975">,</offsets><xref rid="pmed-0040076-b014" ref-type="bibr"><offsets xml_i="17881" xml_f="17883" txt_i="9975" txt_f="9977">14</offsets></xref><offsets xml_i="17890" xml_f="18071" txt_i="9977" txt_f="10158">], suggesting a direct link between SIRT1 and mitochondrial bioenergetics. Currently, there no data in human skeletal muscle on how caloric restriction may affect the expression of </offsets><italic><offsets xml_i="18079" xml_f="18087" txt_i="10158" txt_f="10166">PPARGC1A</offsets></italic><offsets xml_i="18096" xml_f="18101" txt_i="10166" txt_f="10171"> and </offsets><italic><offsets xml_i="18109" xml_f="18115" txt_i="10171" txt_f="10177">SIRT1,</offsets></italic><offsets xml_i="18124" xml_f="18170" txt_i="10177" txt_f="10223"> as well as mitochondrial number and function.</offsets></p><p><offsets xml_i="18177" xml_f="18366" txt_i="10224" txt_f="10413">Research strongly supports the health benefits of exercise in humans of all ages. Increased exercise in the absence of other behavioral changes prevents the onset of many chronic diseases [</offsets><xref rid="pmed-0040076-b015" ref-type="bibr"><offsets xml_i="18412" xml_f="18414" txt_i="10413" txt_f="10415">15</offsets></xref><offsets xml_i="18421" xml_f="18538" txt_i="10415" txt_f="10532">]. In addition, the combination of weight loss and exercise in overweight individuals increases insulin sensitivity [</offsets><xref rid="pmed-0040076-b016" ref-type="bibr"><offsets xml_i="18584" xml_f="18586" txt_i="10532" txt_f="10534">16</offsets></xref><offsets xml_i="18593" xml_f="18596" txt_i="10534" txt_f="10537">], </offsets><italic><offsets xml_i="18604" xml_f="18612" txt_i="10537" txt_f="10545">PPARGC1A</offsets></italic><offsets xml_i="18621" xml_f="18639" txt_i="10545" txt_f="10563"> gene expression [</offsets><xref rid="pmed-0040076-b017" ref-type="bibr"><offsets xml_i="18685" xml_f="18687" txt_i="10563" txt_f="10565">17</offsets></xref><offsets xml_i="18694" xml_f="18725" txt_i="10565" txt_f="10596">], and mitochondrial function [</offsets><xref rid="pmed-0040076-b016" ref-type="bibr"><offsets xml_i="18771" xml_f="18773" txt_i="10596" txt_f="10598">16</offsets></xref><offsets xml_i="18780" xml_f="19317" txt_i="10598" txt_f="11135">]. However, to our knowledge no study has addressed the interactive effects of diet and exercise on skeletal muscle mitochondrial function in non-obese humans. The aims of this study was to test the hypothesis that short-term caloric deficit (caloric restriction with or without exercise) would coordinately up-regulate the expression of genes involved in mitochondrial biogenesis in skeletal muscle resulting in increased mitochondrial content, improved whole body energy efficiency, and decreased DNA fragmentation in non-obese humans.</offsets></p></sec><sec id="s2"><title><offsets xml_i="19347" xml_f="19354" txt_i="11137" txt_f="11144">Methods</offsets></title><sec id="s2a"><title><offsets xml_i="19383" xml_f="19395" txt_i="11145" txt_f="11157">Participants</offsets></title><p><offsets xml_i="19406" xml_f="19459" txt_i="11158" txt_f="11211">Participants were recruited as previously described [</offsets><xref rid="pmed-0040076-b018" ref-type="bibr"><offsets xml_i="19505" xml_f="19507" txt_i="11211" txt_f="11213">18</offsets></xref><offsets xml_i="19514" xml_f="19712" txt_i="11213" txt_f="11411">] and gave their written informed consent to provide biopsy samples for muscle molecular analysis. However, the specific muscle bioenergetic tests conducted in this study were not prespecified (see </offsets><xref ref-type="supplementary-material" rid="pmed-0040076-sd001"><offsets xml_i="19777" xml_f="19788" txt_i="11411" txt_f="11422">Protocol S1</offsets></xref><offsets xml_i="19795" xml_f="19912" txt_i="11422" txt_f="11536">). Briefly, healthy, male (25–50 y) and female (25–45 y), overweight participants (body mass index, 25 to &lt;30 kg/m</offsets><sup><offsets xml_i="19917" xml_f="19918" txt_i="11536" txt_f="11537">2</offsets></sup><offsets xml_i="19924" xml_f="19974" txt_i="11537" txt_f="11587">) were enrolled in the study (trial registration: </offsets><ext-link ext-link-type="uri" xlink:href="http://www.ClinicalTrials.gov"><offsets xml_i="20047" xml_f="20076" txt_i="11587" txt_f="11616">http://www.ClinicalTrials.gov</offsets></ext-link><offsets xml_i="20087" xml_f="20285" txt_i="11616" txt_f="11814">; identifier: NCT00099151). The baseline period was conducted over 5 wk to carefully determine individual energy requirements by two 2-wk measures of doubly labeled water during weight maintenance [</offsets><xref rid="pmed-0040076-b018" ref-type="bibr"><offsets xml_i="20331" xml_f="20333" txt_i="11814" txt_f="11816">18</offsets></xref><offsets xml_i="20340" xml_f="20504" txt_i="11816" txt_f="11980">]. The participants then attended a 5-d inpatient stay during which metabolic tests were conducted and the 5-d inpatient stay was repeated after 6 mo. Individuals (</offsets><italic><offsets xml_i="20512" xml_f="20513" txt_i="11980" txt_f="11981">n</offsets></italic><offsets xml_i="20522" xml_f="20801" txt_i="11981" txt_f="12260"> = 36) were randomized into one of three groups for 6 mo: Control, weight maintenance diet; CR, 25% calorie restriction of baseline energy requirements; and caloric restriction with exercise (CREX), 12.5% CR + 12.5% increase in EE by structured exercise as previously described [</offsets><xref rid="pmed-0040076-b018" ref-type="bibr"><offsets xml_i="20847" xml_f="20849" txt_i="12260" txt_f="12262">18</offsets></xref><offsets xml_i="20856" xml_f="21220" txt_i="12262" txt_f="12626">]. All diets were based on the American Heart Association recommendations (≤30% fat). CREX participants increased EE by 12.5% above baseline energy requirements by undergoing structured exercise (walking, running, stationary cycling) 5 d/wk with three sessions under direct supervision and two with heart rate monitoring. EE was measured in a respiratory chamber [</offsets><xref rid="pmed-0040076-b018" ref-type="bibr"><offsets xml_i="21266" xml_f="21268" txt_i="12626" txt_f="12628">18</offsets></xref><offsets xml_i="21275" xml_f="21471" txt_i="12628" txt_f="12824">]. The Internal Review Board of the Pennington Biomedical Research Center and the data safety monitoring board of CALERIE approved the protocol, and participants provided written informed consent.</offsets></p></sec><sec id="s2b"><title><offsets xml_i="21502" xml_f="21522" txt_i="12826" txt_f="12846">Biochemical Analysis</offsets></title><p><offsets xml_i="21533" xml_f="21613" txt_i="12847" txt_f="12927">Body fat was measured by dual energy x-ray absorptiometry (QDA 4500A, Hologics, </offsets><ext-link ext-link-type="uri" xlink:href="http://www.hologic.com"><offsets xml_i="21679" xml_f="21701" txt_i="12927" txt_f="12949">http://www.hologic.com</offsets></ext-link><offsets xml_i="21712" xml_f="21761" txt_i="12949" txt_f="12998">). Fasting serum insulin and tri-iodothyronine (T</offsets><sub><offsets xml_i="21766" xml_f="21767" txt_i="12998" txt_f="12999">3</offsets></sub><offsets xml_i="21773" xml_f="21859" txt_i="12999" txt_f="13085">) levels were measured using immunoassays (DPC 2000, Diagnostic Products Corporation, </offsets><ext-link ext-link-type="uri" xlink:href="http://www.dpc.com"><offsets xml_i="21921" xml_f="21939" txt_i="13085" txt_f="13103">http://www.dpc.com</offsets></ext-link><offsets xml_i="21950" xml_f="22039" txt_i="13103" txt_f="13192">). Plasma glucose was analyzed using a glucose oxidase electrode (Synchron CX7, Beckman, </offsets><ext-link ext-link-type="uri" xlink:href="http://www.beckmancoulter.com"><offsets xml_i="22112" xml_f="22141" txt_i="13192" txt_f="13221">http://www.beckmancoulter.com</offsets></ext-link><offsets xml_i="22152" xml_f="22225" txt_i="13221" txt_f="13294">), whereas adiponectin was determined using nonradioactive ELISA (Linco, </offsets><ext-link ext-link-type="uri" xlink:href="http://www.lincoresearch.com"><offsets xml_i="22297" xml_f="22325" txt_i="13294" txt_f="13322">http://www.lincoresearch.com</offsets></ext-link><offsets xml_i="22336" xml_f="22338" txt_i="13322" txt_f="13324">).</offsets></p></sec><sec id="s2c"><title><offsets xml_i="22369" xml_f="22407" txt_i="13326" txt_f="13364">mRNA Quantification of Gene Expression</offsets></title><p><offsets xml_i="22418" xml_f="22525" txt_i="13365" txt_f="13472">Vastus lateralis biopsy samples (~150 mg) were taken after local anesthesia using the Bergstrom technique [</offsets><xref rid="pmed-0040076-b019" ref-type="bibr"><offsets xml_i="22571" xml_f="22573" txt_i="13472" txt_f="13474">19</offsets></xref><offsets xml_i="22580" xml_f="22864" txt_i="13474" txt_f="13758">]. Fat and connective tissue was removed from the biopsy sample and muscle was snap frozen in liquid nitrogen and stored at −80°C until completion of the study. RNA was isolated from approximately 30 mg of tissue using the acid phenol method and purified with RNeasy columns (Qiagen, </offsets><ext-link ext-link-type="uri" xlink:href="http://www.qiagen.com"><offsets xml_i="22929" xml_f="22950" txt_i="13758" txt_f="13779">http://www.qiagen.com</offsets></ext-link><offsets xml_i="22961" xml_f="23175" txt_i="13779" txt_f="13993">). DNA was extracted from the same tissue samples, after degradation of protein and RNA with Trizol, by phenol-chloroform extraction and ethanol precipitation according to the manufacturer's procedure (Invitrogen, </offsets><ext-link ext-link-type="uri" xlink:href="http://www.invitrogen.com"><offsets xml_i="23244" xml_f="23269" txt_i="13993" txt_f="14018">http://www.invitrogen.com</offsets></ext-link><offsets xml_i="23280" xml_f="23303" txt_i="14018" txt_f="14041">). Primers and probes (</offsets><xref ref-type="supplementary-material" rid="pmed-0040076-st001"><offsets xml_i="23368" xml_f="23376" txt_i="14041" txt_f="14049">Table S1</offsets></xref><offsets xml_i="23383" xml_f="23436" txt_i="14049" txt_f="14102">) were designed using Beacon Designer V2.1 (Bio-Rad, </offsets><ext-link ext-link-type="uri" xlink:href="http://www.bio-rad.com"><offsets xml_i="23502" xml_f="23524" txt_i="14102" txt_f="14124">http://www.bio-rad.com</offsets></ext-link><offsets xml_i="23535" xml_f="23621" txt_i="14124" txt_f="14210">). qRT (quantitative real-time)-PCR reactions were performed as previously described [</offsets><xref rid="pmed-0040076-b020" ref-type="bibr"><offsets xml_i="23667" xml_f="23669" txt_i="14210" txt_f="14212">20</offsets></xref><offsets xml_i="23676" xml_f="23755" txt_i="14212" txt_f="14291">]. All expression data were normalized by dividing the target gene by RPLPO or </offsets><italic><offsets xml_i="23763" xml_f="23796" txt_i="14291" txt_f="14324">peptidylprolyl isomerase B (PPIB)</offsets></italic><offsets xml_i="23805" xml_f="23841" txt_i="14324" txt_f="14360"> mRNA (which encodes cyclophilin B).</offsets></p></sec><sec id="s2d"><title><offsets xml_i="23872" xml_f="23907" txt_i="14362" txt_f="14397">Real-Time PCR for Mitochondrial DNA</offsets></title><p><offsets xml_i="23918" xml_f="24032" txt_i="14398" txt_f="14512">Relative amounts of nuclear DNA and mitochondrial DNA (mtDNA) were determined by qRT-PCR as previously described [</offsets><xref rid="pmed-0040076-b021" ref-type="bibr"><offsets xml_i="24078" xml_f="24080" txt_i="14512" txt_f="14514">21</offsets></xref><offsets xml_i="24087" xml_f="24183" txt_i="14514" txt_f="14610">]. The ratio of mtDNA to nuclear DNA reflects the tissue concentration of mitochondria per cell.</offsets></p></sec><sec id="s2e"><title><offsets xml_i="24214" xml_f="24261" txt_i="14612" txt_f="14659">Skeletal Muscle Mitochondrial Enzyme Activities</offsets></title><p><offsets xml_i="24272" xml_f="24461" txt_i="14660" txt_f="14849">Citrate synthase, beta-hydroxyacyl-CoA dehydrogenase and cytochrome C oxidase II activities were determined spectrophotometrically in muscle homogenates using previously described methods [</offsets><xref rid="pmed-0040076-b022" ref-type="bibr"><offsets xml_i="24507" xml_f="24509" txt_i="14849" txt_f="14851">22</offsets></xref><offsets xml_i="24516" xml_f="24639" txt_i="14851" txt_f="14974">]. Briefly, about 50 mg of skeletal muscle was weighed, diluted 20-fold in extraction buffer and then homogenized (0.1 M KH</offsets><sub><offsets xml_i="24644" xml_f="24645" txt_i="14974" txt_f="14975">2</offsets></sub><offsets xml_i="24651" xml_f="24653" txt_i="14975" txt_f="14977">PO</offsets><sub><offsets xml_i="24658" xml_f="24659" txt_i="14977" txt_f="14978">4</offsets></sub><offsets xml_i="24665" xml_f="24668" txt_i="14978" txt_f="14981">/Na</offsets><sub><offsets xml_i="24673" xml_f="24674" txt_i="14981" txt_f="14982">2</offsets></sub><offsets xml_i="24680" xml_f="24683" txt_i="14982" txt_f="14985">PHO</offsets><sub><offsets xml_i="24688" xml_f="24689" txt_i="14985" txt_f="14986">4</offsets></sub><offsets xml_i="24695" xml_f="25725" txt_i="14986" txt_f="16016">, 2 mM EDTA [pH = 7.2]). Citrate synthase activity was measured at 37 °C in 0.1 M Tris-HCl (pH 8.3) assay buffer containing 0.12 mM 5,5′-dithio-bis 2-nitrobenzoic acid and 0.6 mM oxaloacetate. After an initial 2-min absorbance reading at 412 nm, the reaction was initiated by adding 3.0 mM acetyl-CoA, and the change in absorbance was measured every 10 s for 7 min. Beta-hydroxyacyl-CoA dehydrogenase activity was measured at 37 °C in assay buffer containing 0.1 M triethanolamine-HCl, 5 mM EDTA, and 0.45 mM NADH (pH 7.0). After an initial 1-min absorbance reading at 340 nm, the reaction was initiated by adding 0.1 mM acetoacetyl-CoA, and the change in absorbance was measured every 10 s for 5 min. Cytochrome C oxidase II was measured at 25 °C in 0.03 M potassium phosphate buffer containing reduced cytochrome C (2 mg/ml) and 4 mM sodium hydrosulfite. The reaction was initiated by the addition of sample and the change of absorbance was measured every 10 s for 5 min at 550 nm and values corrected for total protein (mg/ml).</offsets></p></sec><sec id="s2f"><title><offsets xml_i="25756" xml_f="25783" txt_i="16018" txt_f="16045">Antioxidant Enzyme Activity</offsets></title><p><offsets xml_i="25794" xml_f="25954" txt_i="16046" txt_f="16206">Cell lysates were prepared by sonication in cold 20 mM HEPES buffer (pH 7.2), containing 1 mM EDTA, 210 mM mannitol, and 70 mM sucrose and centrifuged at 1,500 </offsets><italic><offsets xml_i="25962" xml_f="25963" txt_i="16206" txt_f="16207">g</offsets></italic><offsets xml_i="25972" xml_f="26279" txt_i="16207" txt_f="16514"> for 5 min at 4 °C. Total superoxide dismutase (SOD) activity (Cu/Zn-, Mn-, and Fe-SOD) was quantitated by measuring the dismutation of superoxide radicals generated by xanthine oxidase. Enzyme activity was determined by an indirect assay according to the commercially available Cayman Chemicals assay kit (</offsets><ext-link ext-link-type="uri" xlink:href="http://www.caymanchem.com"><offsets xml_i="26348" xml_f="26373" txt_i="16514" txt_f="16539">http://www.caymanchem.com</offsets></ext-link><offsets xml_i="26384" xml_f="26386" txt_i="16539" txt_f="16541">).</offsets></p></sec><sec id="s2g"><title><offsets xml_i="26417" xml_f="26472" txt_i="16543" txt_f="16598">Mitochondrial Membrane Potential and Mitochondrial Mass</offsets></title><p><offsets xml_i="26483" xml_f="26589" txt_i="16599" txt_f="16705">Measurement of mitochondrial membrane potential tetramethylrhodamine ethyl ester (TMRE; Molecular Probes, </offsets><ext-link ext-link-type="uri" xlink:href="http://probes.invitrogen.com"><offsets xml_i="26661" xml_f="26689" txt_i="16705" txt_f="16733">http://probes.invitrogen.com</offsets></ext-link><offsets xml_i="26700" xml_f="26741" txt_i="16733" txt_f="16774">) was performed as previously described [</offsets><xref rid="pmed-0040076-b022" ref-type="bibr"><offsets xml_i="26787" xml_f="26789" txt_i="16774" txt_f="16776">22</offsets></xref><offsets xml_i="26796" xml_f="27404" txt_i="16776" txt_f="17384">]. For quantification of mitochondrial mass we used Mitotracker Green probe (Molecular Probes). Mitotracker Green probe preferentially accumulates in mitochondria regardless of the mitochondrial membrane potential and provides an accurate assessment of mitochondrial mass. Cells were washed with PBS and incubated at 37 °C for 30 min with 100 nM MitoTracker Green FM (Molecular Probes). Cells were harvested using trypsin/EDTA and resuspended in PBS. Fluorescence intensity was detected with excitation and emission wavelengths of 490 and 516 nm, respectively, and values corrected for total protein (mg/ml).</offsets></p></sec><sec id="s2h"><title><offsets xml_i="27435" xml_f="27463" txt_i="17386" txt_f="17414">Skeletal Muscle Cell Culture</offsets></title><p><offsets xml_i="27474" xml_f="27628" txt_i="17415" txt_f="17569">Vastus lateralis muscle biopsies (~100 mg) were obtained from five healthy, normal-weight, young, sedentary individuals (body mass index = 24.1 ± 0.5 kg/m</offsets><sup><offsets xml_i="27633" xml_f="27634" txt_i="17569" txt_f="17570">2</offsets></sup><offsets xml_i="27640" xml_f="27807" txt_i="17570" txt_f="17737">; body fat = 15% ± 1%; fasting glucose concentration = 88 ± 2 mg/dl; fasting plasma insulin = 4.4 ± 0.9 μU/ml). Satellite cells were isolated as previously described [</offsets><xref rid="pmed-0040076-b023" ref-type="bibr"><offsets xml_i="27853" xml_f="27855" txt_i="17737" txt_f="17739">23</offsets></xref><offsets xml_i="27862" xml_f="27959" txt_i="17739" txt_f="17836">]. Cells were seeded into 12-well (RNA/DNA) and six-well plates (protein) at a density of 20 × 10</offsets><sup><offsets xml_i="27964" xml_f="27965" txt_i="17836" txt_f="17837">3</offsets></sup><offsets xml_i="27971" xml_f="27980" txt_i="17837" txt_f="17846"> cells/cm</offsets><sup><offsets xml_i="27985" xml_f="27986" txt_i="17846" txt_f="17847">2</offsets></sup><offsets xml_i="27992" xml_f="28055" txt_i="17847" txt_f="17910">. Cells were grown at 37 °C in a humidified atmosphere of 5% CO</offsets><sub><offsets xml_i="28060" xml_f="28061" txt_i="17910" txt_f="17911">2</offsets></sub><offsets xml_i="28067" xml_f="28316" txt_i="17911" txt_f="18160">. Two pairs of Stealth-small interfering (si) RNAs were chemically synthesized (Invitrogen), annealed, and transfected (200 pmol/ml) into 50%–70% confluent primary human myocytes using GeneSilencer siRNA transfection reagents (Gene Therapy Systems, </offsets><ext-link ext-link-type="uri" xlink:href="http://www.genetherapysystems.com"><offsets xml_i="28393" xml_f="28426" txt_i="18160" txt_f="18193">http://www.genetherapysystems.com</offsets></ext-link><offsets xml_i="28437" xml_f="28641" txt_i="18193" txt_f="18397">). The sequences of the sense siRNAs are as follows; AdipoR1, 5′-AAACAGCACGAAACCAAGCAGAUGG-3′; AdipoR2, 5′-AUGUCCCACUGGGAGACUAUAAUGG-3′. Cells transfected with nonfunctional-jumbled siRNA (mock) (Ambion, </offsets><ext-link ext-link-type="uri" xlink:href="http://www.ambion.com"><offsets xml_i="28706" xml_f="28727" txt_i="18397" txt_f="18418">http://www.ambion.com</offsets></ext-link><offsets xml_i="28738" xml_f="28873" txt_i="18418" txt_f="18553">) were used as negative controls (unpublished data). Differentiation of myoblasts into myotubes was initiated as previously described [</offsets><xref rid="pmed-0040076-b023" ref-type="bibr"><offsets xml_i="28919" xml_f="28921" txt_i="18553" txt_f="18555">23</offsets></xref><offsets xml_i="28928" xml_f="29204" txt_i="18555" txt_f="18827">]. At 72 h after induction of differentiation, the medium was changed and treated with either mammalian globular adiponectin for 48 h (R&amp;D Systems, Minneapolis, MN, USA) or with a nitric oxide donor— 50 μM of 2,2′-(hydroxynitrosohydrazono)bis-ethanimine (DETA-NO) (Sigma, </offsets><ext-link ext-link-type="uri" xlink:href="http://www.sigmaaldrich.com"><offsets xml_i="29275" xml_f="29302" txt_i="18827" txt_f="18854">http://www.sigmaaldrich.com</offsets></ext-link><offsets xml_i="29313" xml_f="29335" txt_i="18854" txt_f="18876">)—once a day for 4 d [</offsets><xref rid="pmed-0040076-b007" ref-type="bibr"><offsets xml_i="29381" xml_f="29382" txt_i="18876" txt_f="18877">7</offsets></xref><offsets xml_i="29389" xml_f="29390" txt_i="18877" txt_f="18878">,</offsets><xref rid="pmed-0040076-b024" ref-type="bibr"><offsets xml_i="29436" xml_f="29438" txt_i="18878" txt_f="18880">24</offsets></xref><offsets xml_i="29445" xml_f="29447" txt_i="18880" txt_f="18882">].</offsets></p></sec><sec id="s2i"><title><offsets xml_i="29478" xml_f="29497" txt_i="18884" txt_f="18903">Statistical Methods</offsets></title><p><offsets xml_i="29508" xml_f="29613" txt_i="18904" txt_f="19009">Data are expressed as means ± standard errors of the mean. Data analysis was performed using SAS v. 9.1 (</offsets><ext-link ext-link-type="uri" xlink:href="http://www.sas.com"><offsets xml_i="29675" xml_f="29693" txt_i="19009" txt_f="19027">http://www.sas.com</offsets></ext-link><offsets xml_i="29704" xml_f="30037" txt_i="19027" txt_f="19360">). Changes from baseline to month 6 were analyzed by analysis of covariance with treatment and time interactions and baseline value included as a covariate. In cell culture experiments, t-tests were used to determine treatment effect. Pearson or Spearman correlations were used where appropriate. Data were considered significant if </offsets><italic><offsets xml_i="30045" xml_f="30046" txt_i="19360" txt_f="19361">p</offsets></italic><offsets xml_i="30055" xml_f="30066" txt_i="19361" txt_f="19369"> &lt; 0.05.</offsets></p></sec></sec><sec id="s3"><title><offsets xml_i="30102" xml_f="30109" txt_i="19372" txt_f="19379">Results</offsets></title><sec id="s3a"><title><offsets xml_i="30138" xml_f="30195" txt_i="19380" txt_f="19437">Caloric Restriction Reduces Whole-Body Energy Expenditure</offsets></title><p><offsets xml_i="30206" xml_f="30278" txt_i="19438" txt_f="19510">Physical and metabolic characteristics of the participants are given in </offsets><xref ref-type="table" rid="pmed-0040076-t001"><offsets xml_i="30325" xml_f="30332" txt_i="19510" txt_f="19517">Table 1</offsets></xref><offsets xml_i="30339" xml_f="30365" txt_i="19517" txt_f="19543"> and described elsewhere [</offsets><xref rid="pmed-0040076-b018" ref-type="bibr"><offsets xml_i="30411" xml_f="30413" txt_i="19543" txt_f="19545">18</offsets></xref><offsets xml_i="30420" xml_f="30486" txt_i="19545" txt_f="19611">]. Body weight was significantly reduced in CR (−10.4% ± 0.9% kg, </offsets><italic><offsets xml_i="30494" xml_f="30495" txt_i="19611" txt_f="19612">p</offsets></italic><offsets xml_i="30504" xml_f="30545" txt_i="19612" txt_f="19650"> &lt; 0.001) and CREX (−10.0% ± 0.8% kg, </offsets><italic><offsets xml_i="30553" xml_f="30554" txt_i="19650" txt_f="19651">p</offsets></italic><offsets xml_i="30563" xml_f="30705" txt_i="19651" txt_f="19790"> &lt; 0.001) groups relative to controls (−1.0% ± 1.1% kg) with significant losses in fat mass (CR, −24% ± 3% kg and CREX, −25% ± 3% kg; both </offsets><italic><offsets xml_i="30713" xml_f="30714" txt_i="19790" txt_f="19791">p</offsets></italic><offsets xml_i="30723" xml_f="30804" txt_i="19791" txt_f="19869"> &lt; 0.001) and fat-free mass (FFM) (CR, −5% ± 1% kg and CREX −3% ± 1% kg, both </offsets><italic><offsets xml_i="30812" xml_f="30813" txt_i="19869" txt_f="19870">p</offsets></italic><offsets xml_i="30822" xml_f="30890" txt_i="19870" txt_f="19935"> &lt; 0.001) but no difference between the two intervention groups [</offsets><xref rid="pmed-0040076-b018" ref-type="bibr"><offsets xml_i="30936" xml_f="30938" txt_i="19935" txt_f="19937">18</offsets></xref><offsets xml_i="30945" xml_f="31032" txt_i="19937" txt_f="20024">]. Absolute 24-h EE was significantly reduced from baseline to month 6 in CR and CREX (</offsets><italic><offsets xml_i="31040" xml_f="31041" txt_i="20024" txt_f="20025">p</offsets></italic><offsets xml_i="31050" xml_f="31063" txt_i="20025" txt_f="20035"> &lt; 0.001, </offsets><xref ref-type="table" rid="pmed-0040076-t001"><offsets xml_i="31110" xml_f="31117" txt_i="20035" txt_f="20042">Table 1</offsets></xref><offsets xml_i="31124" xml_f="31252" txt_i="20042" txt_f="20170">). This decrease in 24-h EE remained significant after adjustment for metabolic body size changes in FFM (CR, −135 ± 42 kcal/d, </offsets><italic><offsets xml_i="31260" xml_f="31261" txt_i="20170" txt_f="20171">p</offsets></italic><offsets xml_i="31270" xml_f="31307" txt_i="20171" txt_f="20208"> = 0.002 and CREX, −117 ± 52 kcal/d, </offsets><italic><offsets xml_i="31315" xml_f="31316" txt_i="20208" txt_f="20209">p</offsets></italic><offsets xml_i="31325" xml_f="31336" txt_i="20209" txt_f="20220"> = 0.008) [</offsets><xref rid="pmed-0040076-b018" ref-type="bibr"><offsets xml_i="31382" xml_f="31384" txt_i="20220" txt_f="20222">18</offsets></xref><offsets xml_i="31391" xml_f="31464" txt_i="20222" txt_f="20295">]. Simultaneously, after 6-mo of intervention, plasma triiodothyronine (T</offsets><sub><offsets xml_i="31469" xml_f="31470" txt_i="20295" txt_f="20296">3</offsets></sub><offsets xml_i="31476" xml_f="31521" txt_i="20296" txt_f="20341">) concentration decreased in CR (−8.9 ng/ml, </offsets><italic><offsets xml_i="31529" xml_f="31530" txt_i="20341" txt_f="20342">p</offsets></italic><offsets xml_i="31539" xml_f="31581" txt_i="20342" txt_f="20381"> &lt; 0.001) and CREX groups (−4.5 ng/ml, </offsets><italic><offsets xml_i="31589" xml_f="31590" txt_i="20381" txt_f="20382">p</offsets></italic><offsets xml_i="31599" xml_f="31626" txt_i="20382" txt_f="20409"> = 0.01), suggesting that T</offsets><sub><offsets xml_i="31631" xml_f="31632" txt_i="20409" txt_f="20410">3</offsets></sub><xref rid="pmed-0040076-b025" ref-type="bibr"><offsets xml_i="31684" xml_f="31686" txt_i="20410" txt_f="20412">25</offsets></xref><offsets xml_i="31693" xml_f="31774" txt_i="20412" txt_f="20493">]. DNA damage was reduced from baseline in the CR (−0.56 ± 0.11 arbitrary units, </offsets><italic><offsets xml_i="31782" xml_f="31783" txt_i="20493" txt_f="20494">p</offsets></italic><offsets xml_i="31792" xml_f="31855" txt_i="20494" txt_f="20557"> = 0.003) and CREX participants (−0.45 ± 0.12 arbitrary units, </offsets><italic><offsets xml_i="31863" xml_f="31864" txt_i="20557" txt_f="20558">p</offsets></italic><offsets xml_i="31873" xml_f="31908" txt_i="20558" txt_f="20593"> = 0.011) but not in the controls [</offsets><xref rid="pmed-0040076-b018" ref-type="bibr"><offsets xml_i="31954" xml_f="31956" txt_i="20593" txt_f="20595">18</offsets></xref><offsets xml_i="31963" xml_f="32205" txt_i="20595" txt_f="20837">]. In addition, the activity of superoxide dismutase (SOD), a free radical scavenging enzyme that catalyzes the breakdown of ROS to hydrogen peroxide and molecular oxygen, tended to decrease in the skeletal muscle of the CR group (−22% ± 9%, </offsets><italic><offsets xml_i="32213" xml_f="32214" txt_i="20837" txt_f="20838">p</offsets></italic><offsets xml_i="32223" xml_f="32232" txt_i="20838" txt_f="20847"> = 0.15).</offsets></p><table-wrap id="pmed-0040076-t001" content-type="1col" position="float"><label><offsets xml_i="32315" xml_f="32322" txt_i="20848" txt_f="20855">Table 1</offsets></label><caption><p><offsets xml_i="32342" xml_f="32402" txt_i="20855" txt_f="20915">Metabolic Characteristics of Subjects Completing the Study (</offsets><italic><offsets xml_i="32410" xml_f="32411" txt_i="20915" txt_f="20916">n</offsets></italic><offsets xml_i="32420" xml_f="32426" txt_i="20916" txt_f="20922"> = 36)</offsets></p></caption><graphic xlink:href="pmed.0040076.t001"></graphic></table-wrap><p><offsets xml_i="32506" xml_f="32651" txt_i="20923" txt_f="21068">Fasting glucose was not changed in any of the groups, whereas fasting insulin was significantly reduced from baseline in the CR and CREX groups (</offsets><xref ref-type="table" rid="pmed-0040076-t001"><offsets xml_i="32698" xml_f="32705" txt_i="21068" txt_f="21075">Table 1</offsets></xref><offsets xml_i="32712" xml_f="32779" txt_i="21075" txt_f="21142">), consistent with an expected improvement in insulin sensitivity [</offsets><xref rid="pmed-0040076-b026" ref-type="bibr"><offsets xml_i="32825" xml_f="32827" txt_i="21142" txt_f="21144">26</offsets></xref><offsets xml_i="32834" xml_f="32835" txt_i="21144" txt_f="21145">–</offsets><xref rid="pmed-0040076-b028" ref-type="bibr"><offsets xml_i="32881" xml_f="32883" txt_i="21145" txt_f="21147">28</offsets></xref><offsets xml_i="32890" xml_f="33023" txt_i="21147" txt_f="21280">]. The potential importance of adiponectin as a mediator of the effects of caloric restriction is underscored by studies in rodents [</offsets><xref rid="pmed-0040076-b029" ref-type="bibr"><offsets xml_i="33069" xml_f="33071" txt_i="21280" txt_f="21282">29</offsets></xref><offsets xml_i="33078" xml_f="33092" txt_i="21282" txt_f="21296">] and humans [</offsets><xref rid="pmed-0040076-b030" ref-type="bibr"><offsets xml_i="33138" xml_f="33140" txt_i="21296" txt_f="21298">30</offsets></xref><offsets xml_i="33147" xml_f="33399" txt_i="21298" txt_f="21550">] demonstrating that caloric restriction improves insulin sensitivity in parallel with an increase in circulating adiponectin. In our study, total plasma adiponectin tended to increase in both intervention groups by 17% ± 1% in CR and 7% ± 1% in CREX (</offsets><xref ref-type="table" rid="pmed-0040076-t001"><offsets xml_i="33446" xml_f="33453" txt_i="21550" txt_f="21557">Table 1</offsets></xref><offsets xml_i="33460" xml_f="33571" txt_i="21557" txt_f="21668">), possibly due to the small sample size and/or differential regulation of the multimeric forms of adiponectin.</offsets></p></sec><sec id="s3b"><title><offsets xml_i="33602" xml_f="33672" txt_i="21670" txt_f="21740">Caloric Restriction Increases Mitochondrial Content in Skeletal Muscle</offsets></title><p><offsets xml_i="33683" xml_f="33764" txt_i="21741" txt_f="21822">Six months of caloric restriction caused an increase in the expression levels of </offsets><italic><offsets xml_i="33772" xml_f="33776" txt_i="21822" txt_f="21826">TFAM</offsets></italic><offsets xml_i="33785" xml_f="33870" txt_i="21826" txt_f="21911"> (the principal transcription factor involved in regulating mtDNA transcription) and </offsets><italic><offsets xml_i="33878" xml_f="33886" txt_i="21911" txt_f="21919">PPARGC1A</offsets></italic><offsets xml_i="33895" xml_f="33897" txt_i="21919" txt_f="21921"> (</offsets><xref ref-type="fig" rid="pmed-0040076-g001"><offsets xml_i="33942" xml_f="33950" txt_i="21921" txt_f="21929">Figure 1</offsets></xref><offsets xml_i="33957" xml_f="33963" txt_i="21929" txt_f="21935">A and </offsets><xref ref-type="fig" rid="pmed-0040076-g001"><offsets xml_i="34008" xml_f="34009" txt_i="21935" txt_f="21936">1</offsets></xref><offsets xml_i="34016" xml_f="34172" txt_i="21936" txt_f="22092">B), suggesting an induction of mitochondrial biogenesis. Consistently, there was a significant induction in mtDNA content (a marker for mitochondrial mass [</offsets><xref rid="pmed-0040076-b031" ref-type="bibr"><offsets xml_i="34218" xml_f="34220" txt_i="22092" txt_f="22094">31</offsets></xref><offsets xml_i="34227" xml_f="34228" txt_i="22094" txt_f="22095">,</offsets><xref rid="pmed-0040076-b032" ref-type="bibr"><offsets xml_i="34274" xml_f="34276" txt_i="22095" txt_f="22097">32</offsets></xref><offsets xml_i="34283" xml_f="34303" txt_i="22097" txt_f="22117">]) in CR (35% ± 5%; </offsets><italic><offsets xml_i="34311" xml_f="34312" txt_i="22117" txt_f="22118">p</offsets></italic><offsets xml_i="34321" xml_f="34351" txt_i="22118" txt_f="22148"> = 0.005) and CREX (21% ± 4%; </offsets><italic><offsets xml_i="34359" xml_f="34360" txt_i="22148" txt_f="22149">p</offsets></italic><offsets xml_i="34369" xml_f="34433" txt_i="22149" txt_f="22213"> = 0.004) groups with no change in the control group (2% ± 2%) (</offsets><xref ref-type="fig" rid="pmed-0040076-g002"><offsets xml_i="34478" xml_f="34486" txt_i="22213" txt_f="22221">Figure 2</offsets></xref><offsets xml_i="34493" xml_f="34901" txt_i="22221" txt_f="22629">A). However, in the three groups, we did not observe any change in citrate synthase protein content, another marker of mitochondrial mass (unpublished data). The activity of beta-hydroxyacyl-CoA dehydrogenase (a measure of β-oxidation), citrate synthase (a measure of TCA cycle activity), and cytochrome C oxidase II (a measure of electron transport chain activity) did not change in response to CR or CREX (</offsets><xref ref-type="fig" rid="pmed-0040076-g002"><offsets xml_i="34946" xml_f="34954" txt_i="22629" txt_f="22637">Figure 2</offsets></xref><offsets xml_i="34961" xml_f="34964" txt_i="22637" txt_f="22640">B).</offsets></p><fig id="pmed-0040076-g001" position="float"><label><offsets xml_i="35020" xml_f="35028" txt_i="22641" txt_f="22649">Figure 1</offsets></label><caption><title><offsets xml_i="35052" xml_f="35125" txt_i="22649" txt_f="22722">Changes in Skeletal Muscle Gene Expression for Key Mitochondrial Proteins</offsets></title><p><offsets xml_i="35136" xml_f="35146" txt_i="22723" txt_f="22733">(A) TFAM: </offsets><sup><offsets xml_i="35151" xml_f="35152" txt_i="22733" txt_f="22734">*</offsets></sup><offsets xml_i="35158" xml_f="35162" txt_i="22734" txt_f="22738">CR, </offsets><italic><offsets xml_i="35170" xml_f="35171" txt_i="22738" txt_f="22739">p</offsets></italic><offsets xml_i="35180" xml_f="35190" txt_i="22739" txt_f="22749"> = 0.001; </offsets><sup><offsets xml_i="35195" xml_f="35196" txt_i="22749" txt_f="22750">#</offsets></sup><offsets xml_i="35202" xml_f="35208" txt_i="22750" txt_f="22756">CREX, </offsets><italic><offsets xml_i="35216" xml_f="35217" txt_i="22756" txt_f="22757">p</offsets></italic><offsets xml_i="35226" xml_f="35235" txt_i="22757" txt_f="22766"> = 0.014.</offsets></p><p><offsets xml_i="35242" xml_f="35256" txt_i="22767" txt_f="22781">(B) PPARGC1A: </offsets><sup><offsets xml_i="35261" xml_f="35262" txt_i="22781" txt_f="22782">*</offsets></sup><offsets xml_i="35268" xml_f="35272" txt_i="22782" txt_f="22786">CR, </offsets><italic><offsets xml_i="35280" xml_f="35281" txt_i="22786" txt_f="22787">p</offsets></italic><offsets xml_i="35290" xml_f="35300" txt_i="22787" txt_f="22797"> = 0.004; </offsets><sup><offsets xml_i="35305" xml_f="35306" txt_i="22797" txt_f="22798">#</offsets></sup><offsets xml_i="35312" xml_f="35318" txt_i="22798" txt_f="22804">CREX, </offsets><italic><offsets xml_i="35326" xml_f="35327" txt_i="22804" txt_f="22805">p</offsets></italic><offsets xml_i="35336" xml_f="35345" txt_i="22805" txt_f="22814"> = 0.002.</offsets></p><p><offsets xml_i="35352" xml_f="35363" txt_i="22815" txt_f="22826">(C) SIRT1: </offsets><sup><offsets xml_i="35368" xml_f="35369" txt_i="22826" txt_f="22827">*</offsets></sup><offsets xml_i="35375" xml_f="35379" txt_i="22827" txt_f="22831">CR, </offsets><italic><offsets xml_i="35387" xml_f="35388" txt_i="22831" txt_f="22832">p</offsets></italic><offsets xml_i="35397" xml_f="35407" txt_i="22832" txt_f="22842"> = 0.016; </offsets><sup><offsets xml_i="35412" xml_f="35413" txt_i="22842" txt_f="22843">#</offsets></sup><offsets xml_i="35419" xml_f="35425" txt_i="22843" txt_f="22849">CREX, </offsets><italic><offsets xml_i="35433" xml_f="35434" txt_i="22849" txt_f="22850">p</offsets></italic><offsets xml_i="35443" xml_f="35452" txt_i="22850" txt_f="22859"> = 0.023.</offsets></p><p><offsets xml_i="35459" xml_f="35469" txt_i="22860" txt_f="22870">(D) eNOS: </offsets><sup><offsets xml_i="35474" xml_f="35475" txt_i="22870" txt_f="22871">*</offsets></sup><offsets xml_i="35481" xml_f="35485" txt_i="22871" txt_f="22875">CR, </offsets><italic><offsets xml_i="35493" xml_f="35494" txt_i="22875" txt_f="22876">p</offsets></italic><offsets xml_i="35503" xml_f="35513" txt_i="22876" txt_f="22886"> = 0.002; </offsets><sup><offsets xml_i="35518" xml_f="35519" txt_i="22886" txt_f="22887">#</offsets></sup><offsets xml_i="35525" xml_f="35531" txt_i="22887" txt_f="22893">CREX, </offsets><italic><offsets xml_i="35539" xml_f="35540" txt_i="22893" txt_f="22894">p</offsets></italic><offsets xml_i="35549" xml_f="35558" txt_i="22894" txt_f="22903"> = 0.039.</offsets></p><p><offsets xml_i="35565" xml_f="36303" txt_i="22904" txt_f="23642">Graphs show six-month changes in enzyme expression in response to each intervention. The y-axis represents the relative gene expression change from baseline for each study group. Each box plot shows the distribution of expression levels from 25th to 75th percentile, and the lines inside the boxes denote the medians. The whiskers denote the interval between the 10th and 90th percentiles. The filled circles mark the data points outside the 10th and 90th percentiles. Molecular analysis was performed in 11 of 12 volunteers per group from whom there was sufficient pre- and postintervention sample for this determination. Changes from baseline to month 6 were analyzed by analysis of variance with baseline values included as covariates.</offsets></p></caption><graphic xlink:href="pmed.0040076.g001"></graphic></fig><fig id="pmed-0040076-g002" position="float"><label><offsets xml_i="36425" xml_f="36433" txt_i="23643" txt_f="23651">Figure 2</offsets></label><caption><title><offsets xml_i="36457" xml_f="36523" txt_i="23651" txt_f="23717">The Effects of Caloric Restriction on Mitochondrial Bionenergetics</offsets></title><p><offsets xml_i="36534" xml_f="36913" txt_i="23718" txt_f="24097">(A and B) Each box plot shows the distribution of expression levels from 25th to 75th percentile and the lines inside the boxes denote the medians. The whiskers denote the interval between the 10th and 90th percentiles. The filled circles mark the data points outside the 10th and 90th percentiles. (A) Caloric deficit–induced mitochondrial biogenesis in the CR group (35% ± 5%, </offsets><sup><offsets xml_i="36918" xml_f="36919" txt_i="24097" txt_f="24098">*</offsets></sup><offsets xml_i="36925" xml_f="36926" txt_i="24098" txt_f="24099">
</offsets><italic><offsets xml_i="36934" xml_f="36935" txt_i="24099" txt_f="24100">p</offsets></italic><offsets xml_i="36944" xml_f="36984" txt_i="24100" txt_f="24140"> = 0.005) and the CREX group (21% ± 4%, </offsets><sup><offsets xml_i="36989" xml_f="36990" txt_i="24140" txt_f="24141">#</offsets></sup><offsets xml_i="36996" xml_f="36997" txt_i="24141" txt_f="24142">
</offsets><italic><offsets xml_i="37005" xml_f="37006" txt_i="24142" txt_f="24143">p</offsets></italic><offsets xml_i="37015" xml_f="37453" txt_i="24143" txt_f="24578"> &lt; 0.004), with no change in the control group (2% ± 2%). The y-axis represents the relative change from baseline in mtDNA for each study group. (B) Analysis of mitochondrial enzyme activity; β-HAD (β-oxidation); CS (TCA cycle), and COX (electron transport chain). The y-axis represents the relative change from baseline in mitochondrial enzyme activity for each study group. (C) Linear correlation between the change from baseline in </offsets><italic><offsets xml_i="37461" xml_f="37466" txt_i="24578" txt_f="24583">SIRT1</offsets></italic><offsets xml_i="37475" xml_f="37480" txt_i="24583" txt_f="24588"> and </offsets><italic><offsets xml_i="37488" xml_f="37496" txt_i="24588" txt_f="24596">PPARGC1A</offsets></italic><offsets xml_i="37505" xml_f="37542" txt_i="24596" txt_f="24633"> mRNAs from baseline in control (○), </offsets><italic><offsets xml_i="37550" xml_f="37551" txt_i="24633" txt_f="24634">r</offsets></italic><offsets xml_i="37560" xml_f="37569" txt_i="24634" txt_f="24643"> = 0.83, </offsets><italic><offsets xml_i="37577" xml_f="37578" txt_i="24643" txt_f="24644">p</offsets></italic><offsets xml_i="37587" xml_f="37607" txt_i="24644" txt_f="24661"> &lt; 0.05; CR (□), </offsets><italic><offsets xml_i="37615" xml_f="37616" txt_i="24661" txt_f="24662">r</offsets></italic><offsets xml_i="37625" xml_f="37634" txt_i="24662" txt_f="24671"> = 0.95, </offsets><italic><offsets xml_i="37642" xml_f="37643" txt_i="24671" txt_f="24672">p</offsets></italic><offsets xml_i="37652" xml_f="37691" txt_i="24672" txt_f="24708"> &lt; 0.01; and CREX participants (▵), </offsets><italic><offsets xml_i="37699" xml_f="37700" txt_i="24708" txt_f="24709">r</offsets></italic><offsets xml_i="37709" xml_f="37718" txt_i="24709" txt_f="24718"> = 0.76, </offsets><italic><offsets xml_i="37726" xml_f="37727" txt_i="24718" txt_f="24719">p</offsets></italic><offsets xml_i="37736" xml_f="37794" txt_i="24719" txt_f="24774"> &lt; 0.05). The linear correlation between the change in </offsets><italic><offsets xml_i="37802" xml_f="37807" txt_i="24774" txt_f="24779">SIRT1</offsets></italic><offsets xml_i="37816" xml_f="37826" txt_i="24779" txt_f="24789"> mRNA and </offsets><italic><offsets xml_i="37834" xml_f="37842" txt_i="24789" txt_f="24797">PPARGC1A</offsets></italic><offsets xml_i="37851" xml_f="37944" txt_i="24797" txt_f="24890"> mRNA from baseline in the CR group (□) remained significant after exclusion of the outlier (</offsets><italic><offsets xml_i="37952" xml_f="37953" txt_i="24890" txt_f="24891">r</offsets></italic><offsets xml_i="37962" xml_f="37971" txt_i="24891" txt_f="24900"> = 0.81, </offsets><italic><offsets xml_i="37979" xml_f="37980" txt_i="24900" txt_f="24901">p</offsets></italic><offsets xml_i="37989" xml_f="38117" txt_i="24901" txt_f="25026"> &lt; 0.01). Changes from baseline to month 6 were analyzed by analysis of variance with baseline values included as covariates.</offsets></p></caption><graphic xlink:href="pmed.0040076.g002"></graphic></fig><p><offsets xml_i="38190" xml_f="38335" txt_i="25027" txt_f="25172">We next examined the skeletal muscle expression of genes involved in oxidative transcription, mitochondrial oxidation, and oxidative stress (see </offsets><xref ref-type="supplementary-material" rid="pmed-0040076-st001"><offsets xml_i="38400" xml_f="38408" txt_i="25172" txt_f="25180">Table S1</offsets></xref><offsets xml_i="38415" xml_f="38448" txt_i="25180" txt_f="25213"> for complete listing of genes). </offsets><italic><offsets xml_i="38456" xml_f="38461" txt_i="25213" txt_f="25218">SIRT1</offsets></italic><offsets xml_i="38470" xml_f="38513" txt_i="25218" txt_f="25261"> mRNA was increased in the CR (113% ± 24%; </offsets><italic><offsets xml_i="38521" xml_f="38522" txt_i="25261" txt_f="25262">p</offsets></italic><offsets xml_i="38531" xml_f="38568" txt_i="25262" txt_f="25299"> = 0.016) and CREX groups (61% ± 8%; </offsets><italic><offsets xml_i="38576" xml_f="38577" txt_i="25299" txt_f="25300">p</offsets></italic><offsets xml_i="38586" xml_f="38597" txt_i="25300" txt_f="25311"> = 0.023) (</offsets><xref ref-type="fig" rid="pmed-0040076-g001"><offsets xml_i="38642" xml_f="38650" txt_i="25311" txt_f="25319">Figure 1</offsets></xref><offsets xml_i="38657" xml_f="38689" txt_i="25319" txt_f="25351">C). Baseline mRNA expression of </offsets><italic><offsets xml_i="38697" xml_f="38705" txt_i="25351" txt_f="25359">PPARGC1A</offsets></italic><offsets xml_i="38714" xml_f="38719" txt_i="25359" txt_f="25364"> and </offsets><italic><offsets xml_i="38727" xml_f="38732" txt_i="25364" txt_f="25369">SIRT1</offsets></italic><offsets xml_i="38741" xml_f="38789" txt_i="25369" txt_f="25417"> were highly correlated in all groups (control, </offsets><italic><offsets xml_i="38797" xml_f="38798" txt_i="25417" txt_f="25418">r</offsets></italic><offsets xml_i="38807" xml_f="38816" txt_i="25418" txt_f="25427"> = 0.81, </offsets><italic><offsets xml_i="38824" xml_f="38825" txt_i="25427" txt_f="25428">p</offsets></italic><offsets xml_i="38834" xml_f="38851" txt_i="25428" txt_f="25442"> &lt; 0.001; CR, </offsets><italic><offsets xml_i="38859" xml_f="38860" txt_i="25442" txt_f="25443">r</offsets></italic><offsets xml_i="38869" xml_f="38878" txt_i="25443" txt_f="25452"> = 0.86, </offsets><italic><offsets xml_i="38886" xml_f="38887" txt_i="25452" txt_f="25453">p</offsets></italic><offsets xml_i="38896" xml_f="38919" txt_i="25453" txt_f="25473"> &lt; 0.001; and CREX, </offsets><italic><offsets xml_i="38927" xml_f="38928" txt_i="25473" txt_f="25474">r</offsets></italic><offsets xml_i="38937" xml_f="38946" txt_i="25474" txt_f="25483"> = 0.85, </offsets><italic><offsets xml_i="38954" xml_f="38955" txt_i="25483" txt_f="25484">p</offsets></italic><offsets xml_i="38964" xml_f="39028" txt_i="25484" txt_f="25545"> &lt; 0.001). Furthermore, the changes from baseline to 6-mo in </offsets><italic><offsets xml_i="39036" xml_f="39044" txt_i="25545" txt_f="25553">PPARGC1A</offsets></italic><offsets xml_i="39053" xml_f="39058" txt_i="25553" txt_f="25558"> and </offsets><italic><offsets xml_i="39066" xml_f="39071" txt_i="25558" txt_f="25563">SIRT1</offsets></italic><offsets xml_i="39080" xml_f="39156" txt_i="25563" txt_f="25639"> were strongly correlated in all participants and in each group separately (</offsets><xref ref-type="fig" rid="pmed-0040076-g002"><offsets xml_i="39201" xml_f="39209" txt_i="25639" txt_f="25647">Figure 2</offsets></xref><offsets xml_i="39216" xml_f="39220" txt_i="25647" txt_f="25651">C). </offsets><italic><offsets xml_i="39228" xml_f="39268" txt_i="25651" txt_f="25691">Endothelial nitric oxide synthase (eNOS)</offsets></italic><offsets xml_i="39277" xml_f="39322" txt_i="25691" txt_f="25736"> gene expression was increased by 67% ± 19% (</offsets><italic><offsets xml_i="39330" xml_f="39331" txt_i="25736" txt_f="25737">p</offsets></italic><offsets xml_i="39340" xml_f="39365" txt_i="25737" txt_f="25762"> = 0.002) and 66% ± 16% (</offsets><italic><offsets xml_i="39373" xml_f="39374" txt_i="25762" txt_f="25763">p</offsets></italic><offsets xml_i="39383" xml_f="39434" txt_i="25763" txt_f="25814"> = 0.039) in the CR and CREX groups, respectively (</offsets><xref ref-type="fig" rid="pmed-0040076-g001"><offsets xml_i="39479" xml_f="39487" txt_i="25814" txt_f="25822">Figure 1</offsets></xref><offsets xml_i="39494" xml_f="39512" txt_i="25822" txt_f="25840">D). The change in </offsets><italic><offsets xml_i="39520" xml_f="39524" txt_i="25840" txt_f="25844">eNOS</offsets></italic><offsets xml_i="39533" xml_f="39612" txt_i="25844" txt_f="25923"> mRNA from baseline was highly correlated with the change in the expression of </offsets><italic><offsets xml_i="39620" xml_f="39628" txt_i="25923" txt_f="25931">PPARGC1A</offsets></italic><offsets xml_i="39637" xml_f="39642" txt_i="25931" txt_f="25936"> and </offsets><italic><offsets xml_i="39650" xml_f="39655" txt_i="25936" txt_f="25941">SIRT1</offsets></italic><offsets xml_i="39664" xml_f="39682" txt_i="25941" txt_f="25959"> in the CR group (</offsets><italic><offsets xml_i="39690" xml_f="39691" txt_i="25959" txt_f="25960">r</offsets></italic><offsets xml_i="39700" xml_f="39709" txt_i="25960" txt_f="25969"> = 0.86, </offsets><italic><offsets xml_i="39717" xml_f="39718" txt_i="25969" txt_f="25970">p</offsets></italic><offsets xml_i="39727" xml_f="39743" txt_i="25970" txt_f="25983"> &lt; 0.001 and </offsets><italic><offsets xml_i="39751" xml_f="39752" txt_i="25983" txt_f="25984">r</offsets></italic><offsets xml_i="39761" xml_f="39770" txt_i="25984" txt_f="25993"> = 0.80, </offsets><italic><offsets xml_i="39778" xml_f="39779" txt_i="25993" txt_f="25994">p</offsets></italic><offsets xml_i="39788" xml_f="39914" txt_i="25994" txt_f="26117"> &lt; 0.001, respectively; unpublished data), suggesting synergistic regulation among PPARGC1A, SIRT1, and eNOS. Furthermore, </offsets><italic><offsets xml_i="39922" xml_f="39973" txt_i="26117" txt_f="26168">presenilin-associated, rhomboid-like protein (PARL)</offsets></italic><offsets xml_i="39982" xml_f="40092" txt_i="26168" txt_f="26278"> and AMP-activated protein kinase alpha 2 (AMPK-α2) mRNA increased relative to baseline in the CR group only (</offsets><italic><offsets xml_i="40100" xml_f="40105" txt_i="26278" txt_f="26283">PARL,</offsets></italic><offsets xml_i="40114" xml_f="40138" txt_i="26283" txt_f="26307"> 25 ± 3 versus 54 ± 11, </offsets><italic><offsets xml_i="40146" xml_f="40147" txt_i="26307" txt_f="26308">p</offsets></italic><offsets xml_i="40156" xml_f="40247" txt_i="26308" txt_f="26399"> = 0.008; AMPK-α2, 387 ± 26 versus 521 ± 59 mRNA/ribosomal protein large, PO (RPLPO) mRNA, </offsets><italic><offsets xml_i="40255" xml_f="40256" txt_i="26399" txt_f="26400">p</offsets></italic><offsets xml_i="40265" xml_f="40274" txt_i="26400" txt_f="26409"> = 0.03).</offsets></p></sec><sec id="s3c"><title><offsets xml_i="40305" xml_f="40383" txt_i="26411" txt_f="26489">Nitric Oxide and Mitochondrial Biogenesis in Primary Human Muscle Cell Culture</offsets></title><p><offsets xml_i="40394" xml_f="40569" txt_i="26490" txt_f="26665">To determine whether nitric oxide (NO) (mimicking eNOS activity) was associated with mitochondrial biogenesis in human skeletal muscle, we treated primary human myotubes (see </offsets><xref ref-type="sec" rid="st2"><offsets xml_i="40600" xml_f="40607" txt_i="26665" txt_f="26672">Methods</offsets></xref><offsets xml_i="40614" xml_f="40757" txt_i="26672" txt_f="26815"> for clinical characteristics of the donors) with the NO donor DETA-NO. A 4-d treatment with 50 μM of DETA-NO increased the mRNA expression of </offsets><italic><offsets xml_i="40765" xml_f="40769" txt_i="26815" txt_f="26819">TFAM</offsets></italic><offsets xml_i="40778" xml_f="40809" txt_i="26819" txt_f="26850"> (0.62 ± 0.1 versus 1.3 ± 0.1, </offsets><italic><offsets xml_i="40817" xml_f="40818" txt_i="26850" txt_f="26851">p</offsets></italic><offsets xml_i="40827" xml_f="40909" txt_i="26851" txt_f="26930"> &lt; 0.001) and induced mitochondrial biogenesis (indicated by MitotrackerGreen, </offsets><xref ref-type="fig" rid="pmed-0040076-g003"><offsets xml_i="40954" xml_f="40962" txt_i="26930" txt_f="26938">Figure 3</offsets></xref><offsets xml_i="40969" xml_f="41071" txt_i="26938" txt_f="27040">A). DETA-NO treatment decreased cytochrome C oxidase II activity (structural component of complex IV; </offsets><xref ref-type="fig" rid="pmed-0040076-g003"><offsets xml_i="41116" xml_f="41124" txt_i="27040" txt_f="27048">Figure 3</offsets></xref><offsets xml_i="41131" xml_f="41193" txt_i="27048" txt_f="27110">B) and increased mitochondrial membrane potential using TMRE (</offsets><xref ref-type="fig" rid="pmed-0040076-g003"><offsets xml_i="41238" xml_f="41246" txt_i="27110" txt_f="27118">Figure 3</offsets></xref><offsets xml_i="41253" xml_f="41256" txt_i="27118" txt_f="27121">C).</offsets></p><fig id="pmed-0040076-g003" position="float"><label><offsets xml_i="41312" xml_f="41320" txt_i="27122" txt_f="27130">Figure 3</offsets></label><caption><title><offsets xml_i="41344" xml_f="41491" txt_i="27130" txt_f="27277">Statistical Dot Plots Showing the Effects of DETA-NO and Adiponectin Treatment on Mitochondrial Content and SIRT1 Protein in Primary Human Myotubes</offsets></title><p><offsets xml_i="41502" xml_f="41602" txt_i="27278" txt_f="27378">(A–C) Effects of 96 h of 50 μM DETA-NO treatment on mitochondrial content (using MitoTracker Green, </offsets><italic><offsets xml_i="41610" xml_f="41611" txt_i="27378" txt_f="27379">p</offsets></italic><offsets xml_i="41620" xml_f="41675" txt_i="27379" txt_f="27434"> = 0.002) (A), electron transport chain activity (COX, </offsets><italic><offsets xml_i="41683" xml_f="41684" txt_i="27434" txt_f="27435">p</offsets></italic><offsets xml_i="41693" xml_f="41752" txt_i="27435" txt_f="27494"> = 0.018) (B), and mitochondrial membrane potential (TMRE, </offsets><italic><offsets xml_i="41760" xml_f="41761" txt_i="27494" txt_f="27495">n</offsets></italic><offsets xml_i="41770" xml_f="41776" txt_i="27495" txt_f="27501"> = 6, </offsets><italic><offsets xml_i="41784" xml_f="41785" txt_i="27501" txt_f="27502">p</offsets></italic><offsets xml_i="41794" xml_f="41894" txt_i="27502" txt_f="27602"> = 0.042) (C). Treatment effect was determined using independent sample t-test. OD, optical density.</offsets></p><p><offsets xml_i="41901" xml_f="42260" txt_i="27603" txt_f="27962">(D) Effects of 50 μM DETA-NO on SIRT1 and β-actin protein (top blots); effects of 0.5 μg/ml of globular adiponectin (gAD) and adiponectin receptor R1- and R2-siRNA on SIRT1 and β-actin protein expression (bottom blots). Immunoblotting was undertaken in three participants and data are shown as a representative blot. Means are denoted by the solid black bars.</offsets></p></caption><graphic xlink:href="pmed.0040076.g003"></graphic></fig></sec><sec id="s3d"><title><offsets xml_i="42357" xml_f="42402" txt_i="27964" txt_f="28009">Adiponectin Signaling Increases SIRT1 Protein</offsets></title><p><offsets xml_i="42413" xml_f="42479" txt_i="28010" txt_f="28076">Examination of SIRT1 mRNA (unpublished data) and protein content (</offsets><xref ref-type="fig" rid="pmed-0040076-g003"><offsets xml_i="42524" xml_f="42532" txt_i="28076" txt_f="28084">Figure 3</offsets></xref><offsets xml_i="42539" xml_f="42732" txt_i="28084" txt_f="28277">D, top) in DETA-NO–treated cells demonstrated no difference relative to untreated cells. However, a 2-d treatment of human myotubes with 0.5 μg/ml globular adiponectin increased SIRT1 protein (</offsets><xref ref-type="fig" rid="pmed-0040076-g003"><offsets xml_i="42777" xml_f="42785" txt_i="28277" txt_f="28285">Figure 3</offsets></xref><offsets xml_i="42792" xml_f="42824" txt_i="28285" txt_f="28317">D, bottom) but had no effect on </offsets><italic><offsets xml_i="42832" xml_f="42837" txt_i="28317" txt_f="28322">SIRT1</offsets></italic><offsets xml_i="42846" xml_f="43081" txt_i="28322" txt_f="28557"> mRNA (unpublished data), indicating post-transcriptional regulation. Knocking down adiponectin receptor (-R1 and -R2 isoforms) gene expression by siRNA blunted the adiponectin-induced SIRT1 protein increase in primary human myotubes (</offsets><xref ref-type="fig" rid="pmed-0040076-g003"><offsets xml_i="43126" xml_f="43134" txt_i="28557" txt_f="28565">Figure 3</offsets></xref><offsets xml_i="43141" xml_f="43152" txt_i="28565" txt_f="28576">D, bottom).</offsets></p></sec></sec><sec id="s4"><title><offsets xml_i="43188" xml_f="43198" txt_i="28579" txt_f="28589">Discussion</offsets></title><p><offsets xml_i="43209" xml_f="44127" txt_i="28590" txt_f="29508">The current study investigated the impact of caloric restriction on muscle mitochondrial function in healthy overweight but non-obese humans. The study provides, to our knowledge, the first evidence that a 25% caloric deficit either by caloric restriction alone or by a combination of caloric restriction and exercise decreased 24 h EE and improved mitochondrial function. Molecular analysis revealed that CR and CREX increased the expression of genes involved in nutrient sensing and mitochondrial biogenesis as well as increasing mitochondrial mass without a change in the activity of key mitochondrial enzymes involved in the Krebs cycle, β-oxidation, and electron transport chain activity. However, caloric restriction decreased markers of oxidative stress. Our results suggest that caloric restriction induces biogenesis of “efficient” mitochondria as an adaptive mechanism, which in turn lowers oxidative stress.</offsets></p><sec id="s4a"><title><offsets xml_i="44152" xml_f="44251" txt_i="29509" txt_f="29608">Caloric Restriction Improves Whole-Body Metabolic Efficiency and Lowers Markers of Oxidative Stress</offsets></title><p><offsets xml_i="44262" xml_f="44419" txt_i="29609" txt_f="29766">One proposed explanation for the beneficial effects of caloric restriction is reduced oxygen consumption, which in turn lowers mitochondrial ROS production [</offsets><xref rid="pmed-0040076-b033" ref-type="bibr"><offsets xml_i="44465" xml_f="44467" txt_i="29766" txt_f="29768">33</offsets></xref><offsets xml_i="44474" xml_f="44675" txt_i="29768" txt_f="29969">]. However, published studies have had conflicting results. In healthy primates, ten to 11 years of caloric restriction lowers resting EE, beyond the decrease attributed to losses in FFM and fat mass [</offsets><xref rid="pmed-0040076-b034" ref-type="bibr"><offsets xml_i="44721" xml_f="44723" txt_i="29969" txt_f="29971">34</offsets></xref><offsets xml_i="44730" xml_f="44731" txt_i="29971" txt_f="29972">,</offsets><xref rid="pmed-0040076-b035" ref-type="bibr"><offsets xml_i="44777" xml_f="44779" txt_i="29972" txt_f="29974">35</offsets></xref><offsets xml_i="44786" xml_f="44912" txt_i="29974" txt_f="30100">]. In rodents, reports have been more divisive with decreased, no change, or increased EE in response to caloric restriction [</offsets><xref rid="pmed-0040076-b007" ref-type="bibr"><offsets xml_i="44958" xml_f="44959" txt_i="30100" txt_f="30101">7</offsets></xref><offsets xml_i="44966" xml_f="44967" txt_i="30101" txt_f="30102">,</offsets><xref rid="pmed-0040076-b036" ref-type="bibr"><offsets xml_i="45013" xml_f="45015" txt_i="30102" txt_f="30104">36</offsets></xref><offsets xml_i="45022" xml_f="45023" txt_i="30104" txt_f="30105">–</offsets><xref rid="pmed-0040076-b039" ref-type="bibr"><offsets xml_i="45069" xml_f="45071" txt_i="30105" txt_f="30107">39</offsets></xref><offsets xml_i="45078" xml_f="45606" txt_i="30107" txt_f="30635">]. In humans we now show that short-term caloric restriction with or without exercise reduces fat mass, FFM, and absolute 24-h EE. However, after correcting for changes in FFM and fat mass, 24-h EE was still lowered by CR or CREX, suggesting that energy deficit rather than caloric restriction per se caused the increase in energy efficiency. These results are consistent with studies in obese and lean individuals in which a 10%–15% reduction in energy requirement was reported for weight maintenance after adjustment for FFM [</offsets><xref rid="pmed-0040076-b040" ref-type="bibr"><offsets xml_i="45652" xml_f="45654" txt_i="30635" txt_f="30637">40</offsets></xref><offsets xml_i="45661" xml_f="45663" txt_i="30637" txt_f="30639">].</offsets></p><p><offsets xml_i="45670" xml_f="45902" txt_i="30640" txt_f="30872">Improvement in whole-body oxygen consumption may therefore be expected to lower ROS production, a normal byproduct of oxidative phosphorylation. ROS are formed by single electron transfer to oxygen generating super oxide radicals (O</offsets><sub><offsets xml_i="45907" xml_f="45908" txt_i="30872" txt_f="30873">2</offsets></sub><offsets xml_i="45914" xml_f="45915" txt_i="30873" txt_f="30874">
</offsets><sup><offsets xml_i="45920" xml_f="45922" txt_i="30874" txt_f="30876">•−</offsets></sup><offsets xml_i="45928" xml_f="45951" txt_i="30876" txt_f="30899">), hydrogen peroxide (H</offsets><sub><offsets xml_i="45956" xml_f="45957" txt_i="30899" txt_f="30900">2</offsets></sub><offsets xml_i="45963" xml_f="45964" txt_i="30900" txt_f="30901">O</offsets><sub><offsets xml_i="45969" xml_f="45970" txt_i="30901" txt_f="30902">2</offsets></sub><offsets xml_i="45976" xml_f="46004" txt_i="30902" txt_f="30930">), and hydroxyl radicals (OH</offsets><sup><offsets xml_i="46009" xml_f="46010" txt_i="30930" txt_f="30931">•</offsets></sup><offsets xml_i="46016" xml_f="46019" txt_i="30931" txt_f="30934">) [</offsets><xref rid="pmed-0040076-b003" ref-type="bibr"><offsets xml_i="46065" xml_f="46066" txt_i="30934" txt_f="30935">3</offsets></xref><offsets xml_i="46073" xml_f="46074" txt_i="30935" txt_f="30936">,</offsets><xref rid="pmed-0040076-b041" ref-type="bibr"><offsets xml_i="46120" xml_f="46122" txt_i="30936" txt_f="30938">41</offsets></xref><offsets xml_i="46129" xml_f="46307" txt_i="30938" txt_f="31116">]. ROS react with DNA, protein, and lipids, leading to oxidative damage. Previous studies have shown that caloric restriction decreases proton leaks and oxidative stress damage [</offsets><xref rid="pmed-0040076-b033" ref-type="bibr"><offsets xml_i="46353" xml_f="46355" txt_i="31116" txt_f="31118">33</offsets></xref><offsets xml_i="46362" xml_f="46363" txt_i="31118" txt_f="31119">,</offsets><xref rid="pmed-0040076-b042" ref-type="bibr"><offsets xml_i="46409" xml_f="46411" txt_i="31119" txt_f="31121">42</offsets></xref><offsets xml_i="46418" xml_f="46496" txt_i="31121" txt_f="31199">]. Low mitochondrial content seems to contribute to increased ROS production [</offsets><xref rid="pmed-0040076-b041" ref-type="bibr"><offsets xml_i="46542" xml_f="46544" txt_i="31199" txt_f="31201">41</offsets></xref><offsets xml_i="46551" xml_f="46697" txt_i="31201" txt_f="31347">]. When mitochondrial mass is reduced, mitochondria have increased “workload,” leading to higher membrane potential and increased ROS production [</offsets><xref rid="pmed-0040076-b003" ref-type="bibr"><offsets xml_i="46743" xml_f="46744" txt_i="31347" txt_f="31348">3</offsets></xref><offsets xml_i="46751" xml_f="46752" txt_i="31348" txt_f="31349">,</offsets><xref rid="pmed-0040076-b006" ref-type="bibr"><offsets xml_i="46798" xml_f="46799" txt_i="31349" txt_f="31350">6</offsets></xref><offsets xml_i="46806" xml_f="46807" txt_i="31350" txt_f="31351">,</offsets><xref rid="pmed-0040076-b007" ref-type="bibr"><offsets xml_i="46853" xml_f="46854" txt_i="31351" txt_f="31352">7</offsets></xref><offsets xml_i="46861" xml_f="46862" txt_i="31352" txt_f="31353">,</offsets><xref rid="pmed-0040076-b041" ref-type="bibr"><offsets xml_i="46908" xml_f="46910" txt_i="31353" txt_f="31355">41</offsets></xref><offsets xml_i="46917" xml_f="47114" txt_i="31355" txt_f="31552">]. Increased mitochondrial mass in response to caloric restriction may therefore be an important adaptive mechanism to reduce oxidative stress without a necessary decrease in cellular respiration [</offsets><xref rid="pmed-0040076-b006" ref-type="bibr"><offsets xml_i="47160" xml_f="47161" txt_i="31552" txt_f="31553">6</offsets></xref><offsets xml_i="47168" xml_f="47169" txt_i="31553" txt_f="31554">,</offsets><xref rid="pmed-0040076-b008" ref-type="bibr"><offsets xml_i="47215" xml_f="47216" txt_i="31554" txt_f="31555">8</offsets></xref><offsets xml_i="47223" xml_f="47542" txt_i="31555" txt_f="31874">]. In our study, DNA damage was reduced from baseline in both the CR and CREX participants with a tendency toward lower SOD activity. These data are consistent with the hypothesis that caloric restriction induces the proliferation of efficient mitochondria and reduces oxidative damage to mtDNA and cellular organelles.</offsets></p></sec><sec id="s4b"><title><offsets xml_i="47573" xml_f="47624" txt_i="31876" txt_f="31927">Caloric Restriction Improves Mitochondrial Function</offsets></title><p><offsets xml_i="47635" xml_f="47831" txt_i="31928" txt_f="32124">To investigate the molecular mechanism(s) by which caloric restriction lowered oxygen consumption per unit of FFM, we determined expression of genes involved in mitochondrial biogenesis including </offsets><italic><offsets xml_i="47839" xml_f="47864" txt_i="32124" txt_f="32149">PPARGC1A, PPARGC1B, NRF1,</offsets></italic><offsets xml_i="47873" xml_f="47878" txt_i="32149" txt_f="32154"> and </offsets><italic><offsets xml_i="47886" xml_f="47890" txt_i="32154" txt_f="32158">TFAM</offsets></italic><offsets xml_i="47899" xml_f="47949" txt_i="32158" txt_f="32208"> in skeletal muscle—a metabolically active organ [</offsets><xref rid="pmed-0040076-b043" ref-type="bibr"><offsets xml_i="47995" xml_f="47997" txt_i="32208" txt_f="32210">43</offsets></xref><offsets xml_i="48004" xml_f="48052" txt_i="32210" txt_f="32258">] reported to be involved in the aging process [</offsets><xref rid="pmed-0040076-b044" ref-type="bibr"><offsets xml_i="48098" xml_f="48100" txt_i="32258" txt_f="32260">44</offsets></xref><offsets xml_i="48107" xml_f="48131" txt_i="32260" txt_f="32284">] and oxidative stress [</offsets><xref rid="pmed-0040076-b006" ref-type="bibr"><offsets xml_i="48177" xml_f="48178" txt_i="32284" txt_f="32285">6</offsets></xref><offsets xml_i="48185" xml_f="48269" txt_i="32285" txt_f="32369">]. Six months of caloric restriction caused an increase in the expression levels of </offsets><italic><offsets xml_i="48277" xml_f="48281" txt_i="32369" txt_f="32373">TFAM</offsets></italic><offsets xml_i="48290" xml_f="48295" txt_i="32373" txt_f="32378"> and </offsets><italic><offsets xml_i="48303" xml_f="48311" txt_i="32378" txt_f="32386">PPARGC1A</offsets></italic><offsets xml_i="48320" xml_f="48575" txt_i="32386" txt_f="32641"> and induced mitochondrial biogenesis. Surprisingly, citrate synthase protein was unchanged in all groups. Several investigators have shown a dissociation between mitochondrial mass and in vitro mitochondrial oxidative capacity after caloric restriction [</offsets><xref rid="pmed-0040076-b045" ref-type="bibr"><offsets xml_i="48621" xml_f="48623" txt_i="32641" txt_f="32643">45</offsets></xref><offsets xml_i="48630" xml_f="48631" txt_i="32643" txt_f="32644">–</offsets><xref rid="pmed-0040076-b048" ref-type="bibr"><offsets xml_i="48677" xml_f="48679" txt_i="32644" txt_f="32646">48</offsets></xref><offsets xml_i="48686" xml_f="48872" txt_i="32646" txt_f="32832">]. In addition, mice treated with the caloric restriction “mimetic” compound resveratrol display elevated hepatic mitochondrial content that is independent of citrate synthase activity [</offsets><xref rid="pmed-0040076-b049" ref-type="bibr"><offsets xml_i="48918" xml_f="48920" txt_i="32832" txt_f="32834">49</offsets></xref><offsets xml_i="48927" xml_f="49249" txt_i="32834" txt_f="33156">]. In line with these results, the activity of citrate synthase, beta-hydroxyacyl-CoA dehydrogenase and cytochrome C oxidase II activity did not change in response to interventions. Our results are in agreement with previous reports indicating oxidative enzyme activity does not improve after weight loss in obese humans [</offsets><xref rid="pmed-0040076-b050" ref-type="bibr"><offsets xml_i="49295" xml_f="49297" txt_i="33156" txt_f="33158">50</offsets></xref><offsets xml_i="49304" xml_f="49305" txt_i="33158" txt_f="33159">,</offsets><xref rid="pmed-0040076-b051" ref-type="bibr"><offsets xml_i="49351" xml_f="49353" txt_i="33159" txt_f="33161">51</offsets></xref><offsets xml_i="49360" xml_f="49686" txt_i="33161" txt_f="33487">]. Taken together, our results suggest: (1) caloric restriction induces the proliferation of mitochondria with “efficient” electron transport systems coupled to lower whole-body oxygen consumption, and (2) mtDNA or other nonenzymatic markers of mitochondrial mass (i.e., mitochondrial structural proteins such as cardiolipin [</offsets><xref rid="pmed-0040076-b052" ref-type="bibr"><offsets xml_i="49732" xml_f="49734" txt_i="33487" txt_f="33489">52</offsets></xref><offsets xml_i="49741" xml_f="49903" txt_i="33489" txt_f="33651">]) may be better indicators of mitochondrial content than enzyme activities under caloric restriction conditions in humans. In support of this latter hypothesis, </offsets><italic><offsets xml_i="49911" xml_f="49915" txt_i="33651" txt_f="33655">PARL</offsets></italic><offsets xml_i="49924" xml_f="50131" txt_i="33655" txt_f="33862"> gene expression was higher in the CR group at the end of the intervention. PARL is a mitochondrial-specific rhomboid protease involved in the regulation of inner mitochondrial membrane function, structure [</offsets><xref rid="pmed-0040076-b007" ref-type="bibr"><offsets xml_i="50177" xml_f="50178" txt_i="33862" txt_f="33863">7</offsets></xref><offsets xml_i="50185" xml_f="50203" txt_i="33863" txt_f="33881">], and apoptosis [</offsets><xref rid="pmed-0040076-b053" ref-type="bibr"><offsets xml_i="50249" xml_f="50251" txt_i="33881" txt_f="33883">53</offsets></xref><offsets xml_i="50258" xml_f="50397" txt_i="33883" txt_f="34022">]. A similar induction in mitochondrial fusion gene expression (mitofusin 1 and 2) has been reported after caloric restriction in rodents [</offsets><xref rid="pmed-0040076-b007" ref-type="bibr"><offsets xml_i="50443" xml_f="50444" txt_i="34022" txt_f="34023">7</offsets></xref><offsets xml_i="50451" xml_f="50453" txt_i="34023" txt_f="34025">].</offsets></p></sec><sec id="s4c"><title><offsets xml_i="50484" xml_f="50591" txt_i="34027" txt_f="34134">Caloric Restriction Increases Expression of Genes Involved in Mitochondrial Biogenesis and Nutrient Sensing</offsets></title><p><offsets xml_i="50602" xml_f="50741" txt_i="34135" txt_f="34274">In rodents, the expression of SIRT1 is increased in response to prolonged caloric restriction in adipose, liver, kidney, and brain tissue [</offsets><xref rid="pmed-0040076-b007" ref-type="bibr"><offsets xml_i="50787" xml_f="50788" txt_i="34274" txt_f="34275">7</offsets></xref><offsets xml_i="50795" xml_f="50796" txt_i="34275" txt_f="34276">,</offsets><xref rid="pmed-0040076-b054" ref-type="bibr"><offsets xml_i="50842" xml_f="50844" txt_i="34276" txt_f="34278">54</offsets></xref><offsets xml_i="50851" xml_f="50955" txt_i="34278" txt_f="34382">]. SIRT1 is known to bind, deacetylate, and activate PPARGC1A, thus promoting mitochondrial biogenesis [</offsets><xref rid="pmed-0040076-b011" ref-type="bibr"><offsets xml_i="51001" xml_f="51003" txt_i="34382" txt_f="34384">11</offsets></xref><offsets xml_i="51010" xml_f="51160" txt_i="34384" txt_f="34534">]. Such results raise the possibility that SIRT1 may improve mitochondrial function and lower oxidative damage in humans. In support of this concept, </offsets><italic><offsets xml_i="51168" xml_f="51173" txt_i="34534" txt_f="34539">SIRT1</offsets></italic><offsets xml_i="51182" xml_f="51261" txt_i="34539" txt_f="34618"> mRNA was increased in the CR and CREX groups in proportion to the increase in </offsets><italic><offsets xml_i="51269" xml_f="51277" txt_i="34618" txt_f="34626">PPARGC1A</offsets></italic><offsets xml_i="51286" xml_f="51362" txt_i="34626" txt_f="34702"> mRNA, consistent with the potential role of SIRT1 as a direct regulator of </offsets><italic><offsets xml_i="51370" xml_f="51378" txt_i="34702" txt_f="34710">PPARGC1A</offsets></italic><offsets xml_i="51387" xml_f="51398" txt_i="34710" txt_f="34721"> activity [</offsets><xref rid="pmed-0040076-b011" ref-type="bibr"><offsets xml_i="51444" xml_f="51446" txt_i="34721" txt_f="34723">11</offsets></xref><offsets xml_i="51453" xml_f="51454" txt_i="34723" txt_f="34724">,</offsets><xref rid="pmed-0040076-b014" ref-type="bibr"><offsets xml_i="51500" xml_f="51502" txt_i="34724" txt_f="34726">14</offsets></xref><offsets xml_i="51509" xml_f="51576" txt_i="34726" txt_f="34793">]. We observed a smaller induction in mitochondrial biogenesis and </offsets><italic><offsets xml_i="51584" xml_f="51589" txt_i="34793" txt_f="34798">SIRT1</offsets></italic><offsets xml_i="51598" xml_f="51756" txt_i="34798" txt_f="34956"> mRNA in the CREX relative to CR group. The disparity in the molecular adaptation between CR and CREX groups may relate to SIRT1 activity and the ratio of NAD</offsets><sup><offsets xml_i="51761" xml_f="51762" txt_i="34956" txt_f="34957">+</offsets></sup><offsets xml_i="51768" xml_f="51829" txt_i="34957" txt_f="35018">/NADH, which oscillates depending on the rate of glycolysis [</offsets><xref rid="pmed-0040076-b055" ref-type="bibr"><offsets xml_i="51875" xml_f="51877" txt_i="35018" txt_f="35020">55</offsets></xref><offsets xml_i="51884" xml_f="51918" txt_i="35020" txt_f="35054">] and during submaximal exercise [</offsets><xref rid="pmed-0040076-b056" ref-type="bibr"><offsets xml_i="51964" xml_f="51966" txt_i="35054" txt_f="35056">56</offsets></xref><offsets xml_i="51973" xml_f="52132" txt_i="35056" txt_f="35215">]. This might be expected to change SIRT1 activity and gene transcription. Conversely, aerobic exercise can independently improve muscle metabolic efficiency [</offsets><xref rid="pmed-0040076-b057" ref-type="bibr"><offsets xml_i="52178" xml_f="52180" txt_i="35215" txt_f="35217">57</offsets></xref><offsets xml_i="52187" xml_f="52188" txt_i="35217" txt_f="35218">,</offsets><xref rid="pmed-0040076-b058" ref-type="bibr"><offsets xml_i="52234" xml_f="52236" txt_i="35218" txt_f="35220">58</offsets></xref><offsets xml_i="52243" xml_f="52311" txt_i="35220" txt_f="35288">] by a contraction-stimulated increase in mitochondrial biogenesis [</offsets><xref rid="pmed-0040076-b059" ref-type="bibr"><offsets xml_i="52357" xml_f="52359" txt_i="35288" txt_f="35290">59</offsets></xref><offsets xml_i="52366" xml_f="52459" txt_i="35290" txt_f="35383">] and the expression of genes encoding proteins involved in mitochondrial function including </offsets><italic><offsets xml_i="52467" xml_f="52484" txt_i="35383" txt_f="35400">PPARGC1A, PPAR-δ,</offsets></italic><offsets xml_i="52493" xml_f="52498" txt_i="35400" txt_f="35405"> and </offsets><italic><offsets xml_i="52506" xml_f="52531" txt_i="35405" txt_f="35430">PGC-1-related coactivator</offsets></italic><offsets xml_i="52540" xml_f="52542" txt_i="35430" txt_f="35432"> [</offsets><xref rid="pmed-0040076-b017" ref-type="bibr"><offsets xml_i="52588" xml_f="52590" txt_i="35432" txt_f="35434">17</offsets></xref><offsets xml_i="52597" xml_f="52598" txt_i="35434" txt_f="35435">,</offsets><xref rid="pmed-0040076-b060" ref-type="bibr"><offsets xml_i="52644" xml_f="52646" txt_i="35435" txt_f="35437">60</offsets></xref><offsets xml_i="52653" xml_f="52655" txt_i="35437" txt_f="35439">].</offsets></p><p><offsets xml_i="52662" xml_f="52690" txt_i="35440" txt_f="35468">In rodents, knockout of the </offsets><italic><offsets xml_i="52698" xml_f="52702" txt_i="35468" txt_f="35472">eNOS</offsets></italic><offsets xml_i="52711" xml_f="52773" txt_i="35472" txt_f="35534"> gene abolishes the caloric restriction-induced expression of </offsets><italic><offsets xml_i="52781" xml_f="52789" txt_i="35534" txt_f="35542">PPARGC1A</offsets></italic><offsets xml_i="52798" xml_f="52803" txt_i="35542" txt_f="35547"> and </offsets><italic><offsets xml_i="52811" xml_f="52815" txt_i="35547" txt_f="35551">TFAM</offsets></italic><offsets xml_i="52824" xml_f="52865" txt_i="35551" txt_f="35592"> mRNA and mitochondrial protein content [</offsets><xref rid="pmed-0040076-b007" ref-type="bibr"><offsets xml_i="52911" xml_f="52912" txt_i="35592" txt_f="35593">7</offsets></xref><offsets xml_i="52919" xml_f="52936" txt_i="35593" txt_f="35610">]. Consistently, </offsets><italic><offsets xml_i="52944" xml_f="52948" txt_i="35610" txt_f="35614">eNOS</offsets></italic><offsets xml_i="52957" xml_f="53171" txt_i="35614" txt_f="35828"> gene expression was increased in both intervention groups, suggesting an important role of eNOS in mitochondrial biogenesis in human muscle. In various cell systems, NO treatment induces mitochondrial biogenesis [</offsets><xref rid="pmed-0040076-b061" ref-type="bibr"><offsets xml_i="53217" xml_f="53219" txt_i="35828" txt_f="35830">61</offsets></xref><offsets xml_i="53226" xml_f="53234" txt_i="35830" txt_f="35838">] via a </offsets><italic><offsets xml_i="53242" xml_f="53250" txt_i="35838" txt_f="35846">PPARGC1A</offsets></italic><offsets xml_i="53259" xml_f="53281" txt_i="35846" txt_f="35868">-dependent mechanism [</offsets><xref rid="pmed-0040076-b007" ref-type="bibr"><offsets xml_i="53327" xml_f="53328" txt_i="35868" txt_f="35869">7</offsets></xref><offsets xml_i="53335" xml_f="53336" txt_i="35869" txt_f="35870">,</offsets><xref rid="pmed-0040076-b024" ref-type="bibr"><offsets xml_i="53382" xml_f="53384" txt_i="35870" txt_f="35872">24</offsets></xref><offsets xml_i="53391" xml_f="53574" txt_i="35872" txt_f="36055">]. In our study, NO treatment of primary cultures of human muscle induced mitochondrial biogenesis. These data are consistent with studies in human U937 cells and rodent L6 myoblast [</offsets><xref rid="pmed-0040076-b007" ref-type="bibr"><offsets xml_i="53620" xml_f="53621" txt_i="36055" txt_f="36056">7</offsets></xref><offsets xml_i="53628" xml_f="53629" txt_i="36056" txt_f="36057">,</offsets><xref rid="pmed-0040076-b024" ref-type="bibr"><offsets xml_i="53675" xml_f="53677" txt_i="36057" txt_f="36059">24</offsets></xref><offsets xml_i="53684" xml_f="53828" txt_i="36059" txt_f="36203">]. This pleiotrophic effect occurs by NO diffusing from the mitochondria to the cytosol in response to a high mitochondrial membrane potential [</offsets><xref rid="pmed-0040076-b062" ref-type="bibr"><offsets xml_i="53874" xml_f="53876" txt_i="36203" txt_f="36205">62</offsets></xref><offsets xml_i="53883" xml_f="53992" txt_i="36205" txt_f="36314">]. NO is a potent inhibitor of oxygen consumption and oxidative phosphorylation by inhibition of complex IV [</offsets><xref rid="pmed-0040076-b063" ref-type="bibr"><offsets xml_i="54038" xml_f="54040" txt_i="36314" txt_f="36316">63</offsets></xref><offsets xml_i="54047" xml_f="54048" txt_i="36316" txt_f="36317">,</offsets><xref rid="pmed-0040076-b064" ref-type="bibr"><offsets xml_i="54094" xml_f="54096" txt_i="36317" txt_f="36319">64</offsets></xref><offsets xml_i="54103" xml_f="54357" txt_i="36319" txt_f="36573">]. Consistently, we observed reduced cytochrome C oxidase II activity and increased mitochondrial membrane potential in primary human myotubes treated with DETA-NO. Both NO and high mitochondrial membrane potential are potent inducers of ROS production [</offsets><xref rid="pmed-0040076-b003" ref-type="bibr"><offsets xml_i="54403" xml_f="54404" txt_i="36573" txt_f="36574">3</offsets></xref><offsets xml_i="54411" xml_f="54412" txt_i="36574" txt_f="36575">,</offsets><xref rid="pmed-0040076-b065" ref-type="bibr"><offsets xml_i="54458" xml_f="54460" txt_i="36575" txt_f="36577">65</offsets></xref><offsets xml_i="54467" xml_f="54718" txt_i="36577" txt_f="36828">]. Taken together, these data suggest that NO can induce mitochondrial biogenesis in human skeletal muscle, but would also promote the production of ROS vis-à-vis elevated mitochondrial membrane potential and reduced electron transport chain activity.</offsets></p></sec><sec id="s4d"><title><offsets xml_i="54749" xml_f="54796" txt_i="36830" txt_f="36877">Adiponectin Induces Expression of SIRT1 Protein</offsets></title><p><offsets xml_i="54807" xml_f="54872" txt_i="36878" txt_f="36943">In murine white adipocytes NO treatment increases SIRT1 protein [</offsets><xref rid="pmed-0040076-b007" ref-type="bibr"><offsets xml_i="54918" xml_f="54919" txt_i="36943" txt_f="36944">7</offsets></xref><offsets xml_i="54926" xml_f="55157" txt_i="36944" txt_f="37175">], suggesting eNOS may also be involved in regulating SIRT1 in skeletal muscle. In this study, NO treatment did not change SIRT1 protein content in primary human myotubes. A possible discrepancy between the study by Nisoli et al. [</offsets><xref rid="pmed-0040076-b007" ref-type="bibr"><offsets xml_i="55203" xml_f="55204" txt_i="37175" txt_f="37176">7</offsets></xref><offsets xml_i="55211" xml_f="55285" txt_i="37176" txt_f="37250">] and ours may relate to tissue- or pathway-specific regulation of SIRT1 [</offsets><xref rid="pmed-0040076-b007" ref-type="bibr"><offsets xml_i="55331" xml_f="55332" txt_i="37250" txt_f="37251">7</offsets></xref><offsets xml_i="55339" xml_f="55340" txt_i="37251" txt_f="37252">,</offsets><xref rid="pmed-0040076-b011" ref-type="bibr"><offsets xml_i="55386" xml_f="55388" txt_i="37252" txt_f="37254">11</offsets></xref><offsets xml_i="55395" xml_f="55756" txt_i="37254" txt_f="37615">]. However, our results indicate that NO can induce mitochondrial biogenesis in human skeletal muscle without increasing SIRT1 protein expression. This suggests that additional factors may be involved in improving mitochondrial function and regulating SIRT1 activity in response to caloric restriction in human muscle. Interestingly, we observed an increase in </offsets><italic><offsets xml_i="55764" xml_f="55771" txt_i="37615" txt_f="37622">AMPK-α2</offsets></italic><offsets xml_i="55780" xml_f="56075" txt_i="37622" txt_f="37917"> mRNA in the CR group, suggesting increased AMPK activity. Previous reports from our laboratory demonstrated that increased signaling through an adiponectin-AMPK interaction stimulates PPARGC1A protein expression and mitochondrial biogenesis, and lowers ROS production in human skeletal muscle [</offsets><xref rid="pmed-0040076-b032" ref-type="bibr"><offsets xml_i="56121" xml_f="56123" txt_i="37917" txt_f="37919">32</offsets></xref><offsets xml_i="56130" xml_f="56499" txt_i="37919" txt_f="38288">]. Consistently, adiponectin-mediated signaling increased SIRT1 protein in primary human myotubes. These data indicate that adiponectin signaling may be involved in the regulation of SIRT1-PPARGC1A protein expression. We hypothesize that some of the metabolic benefits induced by caloric restriction may result from improved secretion of adipokines such as adiponectin.</offsets></p><p><offsets xml_i="56506" xml_f="56617" txt_i="38289" txt_f="38400">A widely accepted view is that long-term caloric restriction improves mitochondrial oxidative phosphorylation [</offsets><xref rid="pmed-0040076-b006" ref-type="bibr"><offsets xml_i="56663" xml_f="56664" txt_i="38400" txt_f="38401">6</offsets></xref><offsets xml_i="56671" xml_f="56961" txt_i="38401" txt_f="38691">], therefore lowers ROS production and oxidative damage. We show, to our knowledge for the first time, that in overweight nonobese humans, short-term caloric restriction lowers whole-body energy expenditure (metabolic adaptation), in parallel with an induction in mitochondrial biogenesis, </offsets><italic><offsets xml_i="56969" xml_f="56977" txt_i="38691" txt_f="38699">PPARGC1A</offsets></italic><offsets xml_i="56986" xml_f="56991" txt_i="38699" txt_f="38704"> and </offsets><italic><offsets xml_i="56999" xml_f="57004" txt_i="38704" txt_f="38709">SIRT1</offsets></italic><offsets xml_i="57013" xml_f="57232" txt_i="38709" txt_f="38928"> mRNA, and a decrease in DNA damage. We therefore propose that caloric restriction induces biogenesis of “efficient” mitochondria in human skeletal muscle as an adaptive mechanism, which in turn lowers oxidative stress.</offsets></p></sec></sec><sec sec-type="supplementary-material" id="s5"><title><offsets xml_i="57302" xml_f="57324" txt_i="38931" txt_f="38953">Supporting Information</offsets></title><supplementary-material content-type="local-data" id="pmed-0040076-sd001"><label><offsets xml_i="57413" xml_f="57424" txt_i="38954" txt_f="38965">Protocol S1</offsets></label><caption><title><offsets xml_i="57448" xml_f="57521" txt_i="38965" txt_f="39038">CALERIE Study Institutional Review Board–Approved Clinical Trial Protocol</offsets></title><p><offsets xml_i="57532" xml_f="57544" txt_i="39039" txt_f="39051">(250 KB PDF)</offsets></p></caption><media xlink:href="pmed.0040076.sd001.pdf"><caption><p><offsets xml_i="57613" xml_f="57649" txt_i="39052" txt_f="39088">Click here for additional data file.</offsets></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pmed-0040076-st001"><label><offsets xml_i="57777" xml_f="57785" txt_i="39089" txt_f="39097">Table S1</offsets></label><caption><title><offsets xml_i="57809" xml_f="57880" txt_i="39097" txt_f="39168">Oligonucleotide Sequences for Primer/Probe Sets Used in TaqMan Analysis</offsets></title><p><offsets xml_i="57891" xml_f="57902" txt_i="39169" txt_f="39180">(50 KB DOC)</offsets></p></caption><media xlink:href="pmed.0040076.st001.doc"><caption><p><offsets xml_i="57971" xml_f="58007" txt_i="39181" txt_f="39217">Click here for additional data file.</offsets></p></caption></media></supplementary-material></sec></body><back><ack><p>The authors want to thank the remaining members of the Penningtin CALERIE Research Team including: Donald Williamson, Frank Greenway, Marlene Most, Jennifer Rood, James DeLany, Steven Anton, Emily York-Crowe, Enette Larson-Meyer, Catherine Champagne, Paula Geiselman, Michael Lefevre, Lilian de Jonge, Jennifer Howard, Jana Ihrig, Brenda Dahmer, Julia Volaufova, Darlene Marquis, Connie Murla, Aimee Stewart, Amanda Broussard, and Vanessa Tarver. We also wish to thank all the visitors who spent so much time participating in this very demanding research study. Finally, we thank Dr. James Trevaskis for his assistance on RNA processing, Ryan McMillan for his support on mitochondrial enzyme analysis, Lauren E. Brown for her work on immunoblotting and Dr. Leanne Redman for her assistance in manuscript preparation. </p></ack><fn-group><fn id="ack1" fn-type="con"><p>
<bold>Author contributions.</bold> AEC, LKH, SRS, and ER designed the study and AEC analyzed the data. AEC, SC, MHH, BU, and WAD performed molecular experiments. ER and the Pennington CALERIE team were responsible for recruitment of study participants. AEC, SC, SRS, and ER contributed to writing the paper.</p></fn><fn id="n101" fn-type="financial-disclosure"><p>
<bold>Funding:</bold> This study was supported by RO1 AG20478 (ER), and partly by a CNRU Center Grant #1P30 DK072476 entitled “Nutritional Programming: Environmental and Molecular Interactions.” The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn><fn id="n102" fn-type="COI-statement"><p>
<bold>Competing Interests:</bold> The authors have declared that no competing interests exist.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term>CR</term><def><p>25% caloric restriction group</p></def></def-item><def-item><term>CREX</term><def><p>caloric restriction group with 12.5% caloric restriction + 12.5% increased energy expenditure</p></def></def-item><def-item><term>DETA-NO</term><def><p>2,2′-(hydroxynitrosohydrazono)bis-ethanimine</p></def></def-item><def-item><term>EE</term><def><p>energy expenditure</p></def></def-item><def-item><term>FFM</term><def><p>fat-free mass</p></def></def-item><def-item><term>mtDNA</term><def><p>mitochondrial DNA</p></def></def-item><def-item><term>NO</term><def><p>nitric oxide</p></def></def-item><def-item><term>qRT-PCR</term><def><p>quantitative real-time PCR</p></def></def-item><def-item><term>ROS</term><def><p>reactive oxygen species</p></def></def-item><def-item><term>siRNA</term><def><p>small interfering RNA</p></def></def-item><def-item><term>TMRE</term><def><p>tetramethylrhodamine ethyl ester.</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="pmed-0040076-b001"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weindruch</surname><given-names>R</given-names></name><name><surname>Naylor</surname><given-names>PH</given-names></name><name><surname>Goldstein</surname><given-names>AL</given-names></name><name><surname>Walford</surname><given-names>RL</given-names></name></person-group>
<year>1988</year>
<article-title>Influences of aging and dietary restriction on serum thymosin alpha 1 levels in mice</article-title>
<source>J Gerontol</source>
<volume>43</volume>
<fpage>B40</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="pmid">3346517</pub-id></element-citation></ref><ref id="pmed-0040076-b002"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ames</surname><given-names>BN</given-names></name><name><surname>Shigenaga</surname><given-names>MK</given-names></name><name><surname>Hagen</surname><given-names>TM</given-names></name></person-group>
<year>1995</year>
<article-title>Mitochondrial decay in aging</article-title>
<source>Biochim Biophys Acta</source>
<volume>1271</volume>
<fpage>165</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="pmid">7599204</pub-id></element-citation></ref><ref id="pmed-0040076-b003"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nicholls</surname><given-names>DG</given-names></name></person-group>
<year>2004</year>
<article-title>Mitochondrial membrane potential and aging</article-title>
<source>Aging Cell</source>
<volume>3</volume>
<fpage>35</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">14965354</pub-id></element-citation></ref><ref id="pmed-0040076-b004"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bevilacqua</surname><given-names>L</given-names></name><name><surname>Ramsey</surname><given-names>JJ</given-names></name><name><surname>Hagopian</surname><given-names>K</given-names></name><name><surname>Weindruch</surname><given-names>R</given-names></name><name><surname>Harper</surname><given-names>ME</given-names></name></person-group>
<year>2004</year>
<article-title>Effects of short- and medium-term calorie restriction on muscle mitochondrial proton leak and reactive oxygen species production</article-title>
<source>Am J Physiol Endocrinol Metab</source>
<volume>286</volume>
<fpage>E852</fpage>
<lpage>861</lpage>
<pub-id pub-id-type="pmid">14736705</pub-id></element-citation></ref><ref id="pmed-0040076-b005"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bevilacqua</surname><given-names>L</given-names></name><name><surname>Ramsey</surname><given-names>JJ</given-names></name><name><surname>Hagopian</surname><given-names>K</given-names></name><name><surname>Weindruch</surname><given-names>R</given-names></name><name><surname>Harper</surname><given-names>ME</given-names></name></person-group>
<year>2005</year>
<article-title>Long-term caloric restriction increases UCP3 content but decreases proton leak and reactive oxygen species production in rat skeletal muscle mitochondria</article-title>
<source>Am J Physiol Endocrinol Metab</source>
<volume>289</volume>
<fpage>E429</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="pmid">15886224</pub-id></element-citation></ref><ref id="pmed-0040076-b006"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lambert</surname><given-names>AJ</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Yardley</surname><given-names>J</given-names></name><name><surname>Edwards</surname><given-names>J</given-names></name><name><surname>Merry</surname><given-names>BJ</given-names></name></person-group>
<year>2004</year>
<article-title>The effect of aging and caloric restriction on mitochondrial protein density and oxygen consumption</article-title>
<source>Exp Gerontol</source>
<volume>39</volume>
<fpage>289</fpage>
<lpage>295</lpage>
<pub-id pub-id-type="pmid">15036388</pub-id></element-citation></ref><ref id="pmed-0040076-b007"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nisoli</surname><given-names>E</given-names></name><name><surname>Tonello</surname><given-names>C</given-names></name><name><surname>Cardile</surname><given-names>A</given-names></name><name><surname>Cozzi</surname><given-names>V</given-names></name><name><surname>Bracale</surname><given-names>R</given-names></name><etal></etal></person-group>
<year>2005</year>
<article-title>Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS</article-title>
<source>Science</source>
<volume>310</volume>
<fpage>314</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="pmid">16224023</pub-id></element-citation></ref><ref id="pmed-0040076-b008"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lopez-Lluch</surname><given-names>G</given-names></name><name><surname>Hunt</surname><given-names>N</given-names></name><name><surname>Jones</surname><given-names>B</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Jamieson</surname><given-names>H</given-names></name><etal></etal></person-group>
<year>2006</year>
<article-title>Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>103</volume>
<fpage>1768</fpage>
<lpage>1773</lpage>
<pub-id pub-id-type="pmid">16446459</pub-id></element-citation></ref><ref id="pmed-0040076-b009"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>St-Pierre</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Krauss</surname><given-names>S</given-names></name><name><surname>Tarr</surname><given-names>PT</given-names></name><name><surname>Yang</surname><given-names>R</given-names></name><etal></etal></person-group>
<year>2003</year>
<article-title>Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1α and 1β (PGC-1α and PGC-1β) in muscle cells</article-title>
<source>J Biol Chem</source>
<volume>278</volume>
<fpage>26597</fpage>
<lpage>26603</lpage>
<pub-id pub-id-type="pmid">12734177</pub-id></element-citation></ref><ref id="pmed-0040076-b010"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Puigserver</surname><given-names>P</given-names></name><name><surname>Andersson</surname><given-names>U</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Adelmant</surname><given-names>G</given-names></name><etal></etal></person-group>
<year>1999</year>
<article-title>Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1</article-title>
<source>Cell</source>
<volume>98</volume>
<fpage>115</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="pmid">10412986</pub-id></element-citation></ref><ref id="pmed-0040076-b011"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rodgers</surname><given-names>JT</given-names></name><name><surname>Lerin</surname><given-names>C</given-names></name><name><surname>Haas</surname><given-names>W</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name><name><surname>Spiegelman</surname><given-names>BM</given-names></name><etal></etal></person-group>
<year>2005</year>
<article-title>Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1</article-title>
<source>Nature</source>
<volume>434</volume>
<fpage>113</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="pmid">15744310</pub-id></element-citation></ref><ref id="pmed-0040076-b012"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>SJ</given-names></name><name><surname>Defossez</surname><given-names>PA</given-names></name><name><surname>Guarente</surname><given-names>L</given-names></name></person-group>
<year>2000</year>
<article-title>Requirement of NAD and SIR2 for life-span extension by calorie restriction in <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content>
</article-title>
<source>Science</source>
<volume>289</volume>
<fpage>2126</fpage>
<lpage>2128</lpage>
<pub-id pub-id-type="pmid">11000115</pub-id></element-citation></ref><ref id="pmed-0040076-b013"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Michishita</surname><given-names>E</given-names></name><name><surname>Park</surname><given-names>JY</given-names></name><name><surname>Burneskis</surname><given-names>JM</given-names></name><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Horikawa</surname><given-names>I</given-names></name></person-group>
<year>2005</year>
<article-title>Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins</article-title>
<source>Mol Biol Cell</source>
<volume>16</volume>
<fpage>4623</fpage>
<lpage>4635</lpage>
<pub-id pub-id-type="pmid">16079181</pub-id></element-citation></ref><ref id="pmed-0040076-b014"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nemoto</surname><given-names>S</given-names></name><name><surname>Fergusson</surname><given-names>MM</given-names></name><name><surname>Finkel</surname><given-names>T</given-names></name></person-group>
<year>2005</year>
<article-title>SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α</article-title>
<source>J Biol Chem</source>
<volume>280</volume>
<fpage>16456</fpage>
<lpage>16460</lpage>
<pub-id pub-id-type="pmid">15716268</pub-id></element-citation></ref><ref id="pmed-0040076-b015"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Villeneuve</surname><given-names>PJ</given-names></name><name><surname>Morrison</surname><given-names>HI</given-names></name><name><surname>Craig</surname><given-names>CL</given-names></name><name><surname>Schaubel</surname><given-names>DE</given-names></name></person-group>
<year>1998</year>
<article-title>Physical activity, physical fitness, and risk of dying</article-title>
<source>Epidemiology</source>
<volume>9</volume>
<fpage>626</fpage>
<lpage>631</lpage>
<pub-id pub-id-type="pmid">9799172</pub-id></element-citation></ref><ref id="pmed-0040076-b016"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Menshikova</surname><given-names>EV</given-names></name><name><surname>Ritov</surname><given-names>VB</given-names></name><name><surname>Toledo</surname><given-names>FG</given-names></name><name><surname>Ferrell</surname><given-names>RE</given-names></name><name><surname>Goodpaster</surname><given-names>BH</given-names></name><etal></etal></person-group>
<year>2005</year>
<article-title>Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity</article-title>
<source>Am J Physiol Endocrinol Metab</source>
<volume>288</volume>
<fpage>E818</fpage>
<lpage>825</lpage>
<pub-id pub-id-type="pmid">15585590</pub-id></element-citation></ref><ref id="pmed-0040076-b017"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Russell</surname><given-names>AP</given-names></name><name><surname>Hesselink</surname><given-names>MK</given-names></name><name><surname>Lo</surname><given-names>SK</given-names></name><name><surname>Schrauwen</surname><given-names>P</given-names></name></person-group>
<year>2005</year>
<article-title>Regulation of metabolic transcriptional co-activators and transcription factors with acute exercise</article-title>
<source>Faseb J</source>
<volume>19</volume>
<fpage>986</fpage>
<lpage>988</lpage>
<pub-id pub-id-type="pmid">15814608</pub-id></element-citation></ref><ref id="pmed-0040076-b018"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heilbronn</surname><given-names>LK</given-names></name><name><surname>de Jonge</surname><given-names>L</given-names></name><name><surname>Frisard</surname><given-names>MI</given-names></name><name><surname>DeLany</surname><given-names>JP</given-names></name><name><surname>Larson-Meyer</surname><given-names>DE</given-names></name><etal></etal></person-group>
<year>2006</year>
<article-title>Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: A randomized controlled trial</article-title>
<source>JAMA</source>
<volume>295</volume>
<fpage>1539</fpage>
<lpage>1548</lpage>
<pub-id pub-id-type="pmid">16595757</pub-id></element-citation></ref><ref id="pmed-0040076-b019"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bergstrom</surname><given-names>J</given-names></name></person-group>
<year>1975</year>
<article-title>Percutaneous needle biopsy of skeletal muscle in physiological and clinical research</article-title>
<source>Scand J Clin Lab Invest</source>
<volume>35</volume>
<fpage>609</fpage>
<lpage>616</lpage>
<pub-id pub-id-type="pmid">1108172</pub-id></element-citation></ref><ref id="pmed-0040076-b020"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Civitarese</surname><given-names>AE</given-names></name><name><surname>Jenkinson</surname><given-names>CP</given-names></name><name><surname>Richardson</surname><given-names>D</given-names></name><name><surname>Bajaj</surname><given-names>M</given-names></name><name><surname>Cusi</surname><given-names>K</given-names></name><etal></etal></person-group>
<year>2004</year>
<article-title>Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of type 2 diabetes</article-title>
<source>Diabetologia</source>
<volume>47</volume>
<fpage>816</fpage>
<lpage>820</lpage>
<pub-id pub-id-type="pmid">15105989</pub-id></element-citation></ref><ref id="pmed-0040076-b021"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bogacka</surname><given-names>I</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name><name><surname>Smith</surname><given-names>SR</given-names></name></person-group>
<year>2005</year>
<article-title>Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo</article-title>
<source>Diabetes</source>
<volume>54</volume>
<fpage>1392</fpage>
<lpage>1399</lpage>
<pub-id pub-id-type="pmid">15855325</pub-id></element-citation></ref><ref id="pmed-0040076-b022"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hulver</surname><given-names>MW</given-names></name><name><surname>Berggren</surname><given-names>JR</given-names></name><name><surname>Carper</surname><given-names>MJ</given-names></name><name><surname>Miyazaki</surname><given-names>M</given-names></name><name><surname>Ntambi</surname><given-names>JM</given-names></name><etal></etal></person-group>
<year>2005</year>
<article-title>Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans</article-title>
<source>Cell Metab</source>
<volume>2</volume>
<fpage>251</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="pmid">16213227</pub-id></element-citation></ref><ref id="pmed-0040076-b023"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ukropcova</surname><given-names>B</given-names></name><name><surname>McNeil</surname><given-names>M</given-names></name><name><surname>Sereda</surname><given-names>O</given-names></name><name><surname>de Jonge</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><etal></etal></person-group>
<year>2005</year>
<article-title>Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor</article-title>
<source>J Clin Invest</source>
<volume>115</volume>
<fpage>1934</fpage>
<lpage>1941</lpage>
<pub-id pub-id-type="pmid">16007256</pub-id></element-citation></ref><ref id="pmed-0040076-b024"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nisoli</surname><given-names>E</given-names></name><name><surname>Clementi</surname><given-names>E</given-names></name><name><surname>Paolucci</surname><given-names>C</given-names></name><name><surname>Cozzi</surname><given-names>V</given-names></name><name><surname>Tonello</surname><given-names>C</given-names></name><etal></etal></person-group>
<year>2003</year>
<article-title>Mitochondrial biogenesis in mammals: The role of endogenous nitric oxide</article-title>
<source>Science</source>
<volume>299</volume>
<fpage>896</fpage>
<lpage>899</lpage>
<pub-id pub-id-type="pmid">12574632</pub-id></element-citation></ref><ref id="pmed-0040076-b025"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Toubro</surname><given-names>S</given-names></name><name><surname>Sorensen</surname><given-names>TI</given-names></name><name><surname>Ronn</surname><given-names>B</given-names></name><name><surname>Christensen</surname><given-names>NJ</given-names></name><name><surname>Astrup</surname><given-names>A</given-names></name></person-group>
<year>1996</year>
<article-title>Twenty-four-hour energy expenditure: The role of body composition, thyroid status, sympathetic activity, and family membership</article-title>
<source>J Clin Endocrinol Metab</source>
<volume>81</volume>
<fpage>2670</fpage>
<lpage>2674</lpage>
<pub-id pub-id-type="pmid">8675595</pub-id></element-citation></ref><ref id="pmed-0040076-b026"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fontana</surname><given-names>L</given-names></name><name><surname>Meyer</surname><given-names>TE</given-names></name><name><surname>Klein</surname><given-names>S</given-names></name><name><surname>Holloszy</surname><given-names>JO</given-names></name></person-group>
<year>2004</year>
<article-title>Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>101</volume>
<fpage>6659</fpage>
<lpage>6663</lpage>
<pub-id pub-id-type="pmid">15096581</pub-id></element-citation></ref><ref id="pmed-0040076-b027"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roth</surname><given-names>GS</given-names></name><name><surname>Lane</surname><given-names>MA</given-names></name><name><surname>Ingram</surname><given-names>DK</given-names></name><name><surname>Mattison</surname><given-names>JA</given-names></name><name><surname>Elahi</surname><given-names>D</given-names></name><etal></etal></person-group>
<year>2002</year>
<article-title>Biomarkers of caloric restriction may predict longevity in humans</article-title>
<source>Science</source>
<volume>297</volume>
<fpage>811</fpage>
<pub-id pub-id-type="pmid">12161648</pub-id></element-citation></ref><ref id="pmed-0040076-b028"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Larson-Meyer</surname><given-names>DE</given-names></name><name><surname>Heilbronn</surname><given-names>LK</given-names></name><name><surname>Redman</surname><given-names>LM</given-names></name><name><surname>Newcomer</surname><given-names>BR</given-names></name><name><surname>Frisard</surname><given-names>MI</given-names></name><etal></etal></person-group>
<year>2006</year>
<article-title>Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects</article-title>
<source>Diabetes Care</source>
<volume>29</volume>
<fpage>1337</fpage>
<lpage>1344</lpage>
<pub-id pub-id-type="pmid">16732018</pub-id></element-citation></ref><ref id="pmed-0040076-b029"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Miura</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>LX</given-names></name><name><surname>Bernier</surname><given-names>M</given-names></name><name><surname>DeCabo</surname><given-names>R</given-names></name><etal></etal></person-group>
<year>2004</year>
<article-title>Circulating adiponectin levels increase in rats on caloric restriction: The potential for insulin sensitization</article-title>
<source>Exp Gerontol</source>
<volume>39</volume>
<fpage>1049</fpage>
<lpage>1059</lpage>
<pub-id pub-id-type="pmid">15236764</pub-id></element-citation></ref><ref id="pmed-0040076-b030"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wolfe</surname><given-names>BE</given-names></name><name><surname>Jimerson</surname><given-names>DC</given-names></name><name><surname>Orlova</surname><given-names>C</given-names></name><name><surname>Mantzoros</surname><given-names>CS</given-names></name></person-group>
<year>2004</year>
<article-title>Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers</article-title>
<source>Clin Endocrinol (Oxf)</source>
<volume>61</volume>
<fpage>332</fpage>
<lpage>338</lpage>
<pub-id pub-id-type="pmid">15355449</pub-id></element-citation></ref><ref id="pmed-0040076-b031"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Hiatt</surname><given-names>WR</given-names></name><name><surname>Barstow</surname><given-names>TJ</given-names></name><name><surname>Brass</surname><given-names>EP</given-names></name></person-group>
<year>1999</year>
<article-title>Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: Alterations with disease</article-title>
<source>Eur J Appl Physiol Occup Physiol</source>
<volume>80</volume>
<fpage>22</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">10367719</pub-id></element-citation></ref><ref id="pmed-0040076-b032"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Civitarese</surname><given-names>AE</given-names></name><name><surname>Ukropcova</surname><given-names>B</given-names></name><name><surname>Carling</surname><given-names>S</given-names></name><name><surname>Hulver</surname><given-names>M</given-names></name><name><surname>Defronzo</surname><given-names>RA</given-names></name><etal></etal></person-group>
<year>2006</year>
<article-title>Role of adiponectin in human skeletal muscle bioenergetics</article-title>
<source>Cell Metab</source>
<volume>4</volume>
<fpage>75</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="pmid">16814734</pub-id></element-citation></ref><ref id="pmed-0040076-b033"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ramsey</surname><given-names>JJ</given-names></name><name><surname>Harper</surname><given-names>ME</given-names></name><name><surname>Weindruch</surname><given-names>R</given-names></name></person-group>
<year>2000</year>
<article-title>Restriction of energy intake, energy expenditure, and aging</article-title>
<source>Free Radic Biol Med</source>
<volume>29</volume>
<fpage>946</fpage>
<lpage>968</lpage>
<pub-id pub-id-type="pmid">11084284</pub-id></element-citation></ref><ref id="pmed-0040076-b034"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blanc</surname><given-names>S</given-names></name><name><surname>Schoeller</surname><given-names>D</given-names></name><name><surname>Kemnitz</surname><given-names>J</given-names></name><name><surname>Weindruch</surname><given-names>R</given-names></name><name><surname>Colman</surname><given-names>R</given-names></name><etal></etal></person-group>
<year>2003</year>
<article-title>Energy expenditure of rhesus monkeys subjected to 11 years of dietary restriction</article-title>
<source>J Clin Endocrinol Metab</source>
<volume>88</volume>
<fpage>16</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="pmid">12519821</pub-id></element-citation></ref><ref id="pmed-0040076-b035"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>DeLany</surname><given-names>JP</given-names></name><name><surname>Hansen</surname><given-names>BC</given-names></name><name><surname>Bodkin</surname><given-names>NL</given-names></name><name><surname>Hannah</surname><given-names>J</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name></person-group>
<year>1999</year>
<article-title>Long-term calorie restriction reduces energy expenditure in aging monkeys</article-title>
<source>J Gerontol A Biol Sci Med Sci</source>
<volume>54</volume>
<fpage>B5</fpage>
<lpage>11</lpage>
<comment>discussion</comment>
<fpage>B12</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">10026648</pub-id></element-citation></ref><ref id="pmed-0040076-b036"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ballor</surname><given-names>DL</given-names></name></person-group>
<year>1991</year>
<article-title>Effect of dietary restriction and/or exercise on 23-h metabolic rate and body composition in female rats</article-title>
<source>J Appl Physiol</source>
<volume>71</volume>
<fpage>801</fpage>
<lpage>806</lpage>
<pub-id pub-id-type="pmid">1757316</pub-id></element-citation></ref><ref id="pmed-0040076-b037"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dulloo</surname><given-names>AG</given-names></name><name><surname>Girardier</surname><given-names>L</given-names></name></person-group>
<year>1993</year>
<article-title>24 hour energy expenditure several months after weight loss in the underfed rat: Evidence for a chronic increase in whole-body metabolic efficiency</article-title>
<source>Int J Obes Relat Metab Disord</source>
<volume>17</volume>
<fpage>115</fpage>
<lpage>123</lpage>
<pub-id pub-id-type="pmid">8384165</pub-id></element-citation></ref><ref id="pmed-0040076-b038"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McCarter</surname><given-names>RJ</given-names></name><name><surname>Palmer</surname><given-names>J</given-names></name></person-group>
<year>1992</year>
<article-title>Energy metabolism and aging: A lifelong study of Fischer 344 rats</article-title>
<source>Am J Physiol</source>
<volume>263</volume>
<fpage>E448</fpage>
<lpage>452</lpage>
<pub-id pub-id-type="pmid">1415524</pub-id></element-citation></ref><ref id="pmed-0040076-b039"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Selman</surname><given-names>C</given-names></name><name><surname>Phillips</surname><given-names>T</given-names></name><name><surname>Staib</surname><given-names>JL</given-names></name><name><surname>Duncan</surname><given-names>JS</given-names></name><name><surname>Leeuwenburgh</surname><given-names>C</given-names></name><etal></etal></person-group>
<year>2005</year>
<article-title>Energy expenditure of calorically restricted rats is higher than predicted from their altered body composition</article-title>
<source>Mech Ageing Dev</source>
<volume>126</volume>
<fpage>783</fpage>
<lpage>793</lpage>
<pub-id pub-id-type="pmid">15888333</pub-id></element-citation></ref><ref id="pmed-0040076-b040"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leibel</surname><given-names>RL</given-names></name><name><surname>Rosenbaum</surname><given-names>M</given-names></name><name><surname>Hirsch</surname><given-names>J</given-names></name></person-group>
<year>1995</year>
<article-title>Changes in energy expenditure resulting from altered body weight</article-title>
<source>N Engl J Med</source>
<volume>332</volume>
<fpage>621</fpage>
<lpage>628</lpage>
<pub-id pub-id-type="pmid">7632212</pub-id></element-citation></ref><ref id="pmed-0040076-b041"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maassen</surname><given-names>JA</given-names></name><name><surname>Janssen</surname><given-names>GM</given-names></name><name><surname>Lemkes</surname><given-names>HH</given-names></name></person-group>
<year>2002</year>
<article-title>Mitochondrial diabetes mellitus</article-title>
<source>J Endocrinol Invest</source>
<volume>25</volume>
<fpage>477</fpage>
<lpage>484</lpage>
<pub-id pub-id-type="pmid">12035948</pub-id></element-citation></ref><ref id="pmed-0040076-b042"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sohal</surname><given-names>RS</given-names></name><name><surname>Agarwal</surname><given-names>S</given-names></name><name><surname>Candas</surname><given-names>M</given-names></name><name><surname>Forster</surname><given-names>MJ</given-names></name><name><surname>Lal</surname><given-names>H</given-names></name></person-group>
<year>1994</year>
<article-title>Effect of age and caloric restriction on DNA oxidative damage in different tissues of C57BL/6 mice</article-title>
<source>Mech Ageing Dev</source>
<volume>76</volume>
<fpage>215</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="pmid">7885066</pub-id></element-citation></ref><ref id="pmed-0040076-b043"><element-citation publication-type="other">
<person-group person-group-type="author"><name><surname>Zurlo</surname><given-names>F</given-names></name><name><surname>Larson</surname><given-names>K</given-names></name><name><surname>Bogardus</surname><given-names>C</given-names></name><name><surname>Ravussin</surname><given-names>E</given-names></name></person-group>
<year>1990</year>
<article-title>Skeletal muscle metabolism is a major determinant of resting energy expenditure</article-title>
<source>J Clin Invest</source>
<fpage>1423</fpage>
<lpage>1427</lpage>
<pub-id pub-id-type="pmid">2243122</pub-id></element-citation></ref><ref id="pmed-0040076-b044"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McCarter</surname><given-names>RJ</given-names></name></person-group>
<year>1990</year>
<article-title>Age-related changes in skeletal muscle function</article-title>
<source>Aging (Milano)</source>
<volume>2</volume>
<fpage>27</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="pmid">2094353</pub-id></element-citation></ref><ref id="pmed-0040076-b045"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baker</surname><given-names>DJ</given-names></name><name><surname>Betik</surname><given-names>AC</given-names></name><name><surname>Krause</surname><given-names>DJ</given-names></name><name><surname>Hepple</surname><given-names>RT</given-names></name></person-group>
<year>2006</year>
<article-title>No decline in skeletal muscle oxidative capacity with aging in long-term calorically restricted rats: Effects are independent of mitochondrial DNA integrity</article-title>
<source>J Gerontol A Biol Sci Med Sci</source>
<volume>61</volume>
<fpage>675</fpage>
<lpage>684</lpage>
<pub-id pub-id-type="pmid">16870628</pub-id></element-citation></ref><ref id="pmed-0040076-b046"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Desai</surname><given-names>VG</given-names></name><name><surname>Weindruch</surname><given-names>R</given-names></name><name><surname>Hart</surname><given-names>RW</given-names></name><name><surname>Feuers</surname><given-names>RJ</given-names></name></person-group>
<year>1996</year>
<article-title>Influences of age and dietary restriction on gastrocnemius electron transport system activities in mice</article-title>
<source>Arch Biochem Biophys</source>
<volume>333</volume>
<fpage>145</fpage>
<lpage>151</lpage>
<pub-id pub-id-type="pmid">8806765</pub-id></element-citation></ref><ref id="pmed-0040076-b047"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hepple</surname><given-names>RT</given-names></name><name><surname>Baker</surname><given-names>DJ</given-names></name><name><surname>Kaczor</surname><given-names>JJ</given-names></name><name><surname>Krause</surname><given-names>DJ</given-names></name></person-group>
<year>2005</year>
<article-title>Long-term caloric restriction abrogates the age-related decline in skeletal muscle aerobic function</article-title>
<source>Faseb J</source>
<volume>19</volume>
<fpage>1320</fpage>
<lpage>1322</lpage>
<pub-id pub-id-type="pmid">15955841</pub-id></element-citation></ref><ref id="pmed-0040076-b048"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sreekumar</surname><given-names>R</given-names></name><name><surname>Unnikrishnan</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>A</given-names></name><name><surname>Nygren</surname><given-names>J</given-names></name><name><surname>Short</surname><given-names>KR</given-names></name><etal></etal></person-group>
<year>2002</year>
<article-title>Effects of caloric restriction on mitochondrial function and gene transcripts in rat muscle</article-title>
<source>Am J Physiol Endocrinol Metab</source>
<volume>283</volume>
<fpage>E38</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="pmid">12067840</pub-id></element-citation></ref><ref id="pmed-0040076-b049"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baur</surname><given-names>JA</given-names></name><name><surname>Pearson</surname><given-names>KJ</given-names></name><name><surname>Price</surname><given-names>NL</given-names></name><name><surname>Jamieson</surname><given-names>HA</given-names></name><name><surname>Lerin</surname><given-names>C</given-names></name><etal></etal></person-group>
<year>2006</year>
<article-title>Resveratrol improves health and survival of mice on a high-calorie diet</article-title>
<source>Nature</source>
<volume>444</volume>
<fpage>337</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="pmid">17086191</pub-id></element-citation></ref><ref id="pmed-0040076-b050"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kempen</surname><given-names>KP</given-names></name><name><surname>Saris</surname><given-names>WH</given-names></name><name><surname>Kuipers</surname><given-names>H</given-names></name><name><surname>Glatz</surname><given-names>JF</given-names></name><name><surname>Van Der Vusse</surname><given-names>GJ</given-names></name></person-group>
<year>1998</year>
<article-title>Skeletal muscle metabolic characteristics before and after energy restriction in human obesity: Fibre type, enzymatic beta-oxidative capacity and fatty acid-binding protein content</article-title>
<source>Eur J Clin Invest</source>
<volume>28</volume>
<fpage>1030</fpage>
<lpage>1037</lpage>
<pub-id pub-id-type="pmid">9893016</pub-id></element-citation></ref><ref id="pmed-0040076-b051"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Simoneau</surname><given-names>JA</given-names></name><name><surname>Veerkamp</surname><given-names>JH</given-names></name><name><surname>Turcotte</surname><given-names>LP</given-names></name><name><surname>Kelley</surname><given-names>DE</given-names></name></person-group>
<year>1999</year>
<article-title>Markers of capacity to utilize fatty acids in human skeletal muscle: Relation To insulin resistance and obesity and effects of weight loss</article-title>
<source>FASEB J</source>
<volume>13</volume>
<fpage>2051</fpage>
<lpage>2060</lpage>
<pub-id pub-id-type="pmid">10544188</pub-id></element-citation></ref><ref id="pmed-0040076-b052"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Menshikova</surname><given-names>EV</given-names></name><name><surname>Ritov</surname><given-names>VB</given-names></name><name><surname>Fairfull</surname><given-names>L</given-names></name><name><surname>Ferrell</surname><given-names>RE</given-names></name><name><surname>Kelley</surname><given-names>DE</given-names></name><etal></etal></person-group>
<year>2006</year>
<article-title>Effects of exercise on mitochondrial content and function in aging human skeletal muscle</article-title>
<source>J Gerontol A Biol Sci Med Sci</source>
<volume>61</volume>
<fpage>534</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="pmid">16799133</pub-id></element-citation></ref><ref id="pmed-0040076-b053"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cipolat</surname><given-names>S</given-names></name><name><surname>Rudka</surname><given-names>T</given-names></name><name><surname>Hartmann</surname><given-names>D</given-names></name><name><surname>Costa</surname><given-names>V</given-names></name><name><surname>Serneels</surname><given-names>L</given-names></name><etal></etal></person-group>
<year>2006</year>
<article-title>Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling</article-title>
<source>Cell</source>
<volume>126</volume>
<fpage>163</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="pmid">16839884</pub-id></element-citation></ref><ref id="pmed-0040076-b054"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cohen</surname><given-names>HY</given-names></name><name><surname>Miller</surname><given-names>C</given-names></name><name><surname>Bitterman</surname><given-names>KJ</given-names></name><name><surname>Wall</surname><given-names>NR</given-names></name><name><surname>Hekking</surname><given-names>B</given-names></name><etal></etal></person-group>
<year>2004</year>
<article-title>Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase</article-title>
<source>Science</source>
<volume>305</volume>
<fpage>390</fpage>
<lpage>392</lpage>
<pub-id pub-id-type="pmid">15205477</pub-id></element-citation></ref><ref id="pmed-0040076-b055"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krebs</surname><given-names>HA</given-names></name><name><surname>Veech</surname><given-names>RL</given-names></name></person-group>
<year>1969</year>
<article-title>Equilibrium relations between pyridine nucleotides and adenine nucleotides and their roles in the regulation of metabolic processes</article-title>
<source>Adv Enzyme Regul</source>
<volume>7</volume>
<fpage>397</fpage>
<lpage>413</lpage>
<pub-id pub-id-type="pmid">4391643</pub-id></element-citation></ref><ref id="pmed-0040076-b056"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sahlin</surname><given-names>K</given-names></name><name><surname>Katz</surname><given-names>A</given-names></name><name><surname>Henriksson</surname><given-names>J</given-names></name></person-group>
<year>1987</year>
<article-title>Redox state and lactate accumulation in human skeletal muscle during dynamic exercise</article-title>
<source>Biochem J</source>
<volume>245</volume>
<fpage>551</fpage>
<lpage>556</lpage>
<pub-id pub-id-type="pmid">3663177</pub-id></element-citation></ref><ref id="pmed-0040076-b057"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koves</surname><given-names>TR</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>An</surname><given-names>J</given-names></name><name><surname>Akimoto</surname><given-names>T</given-names></name><name><surname>Slentz</surname><given-names>D</given-names></name><etal></etal></person-group>
<year>2005</year>
<article-title>Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency</article-title>
<source>J Biol Chem</source>
<volume>280</volume>
<fpage>33588</fpage>
<lpage>33598</lpage>
<pub-id pub-id-type="pmid">16079133</pub-id></element-citation></ref><ref id="pmed-0040076-b058"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Short</surname><given-names>KR</given-names></name><name><surname>Vittone</surname><given-names>JL</given-names></name><name><surname>Bigelow</surname><given-names>ML</given-names></name><name><surname>Proctor</surname><given-names>DN</given-names></name><name><surname>Rizza</surname><given-names>RA</given-names></name><etal></etal></person-group>
<year>2003</year>
<article-title>Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity</article-title>
<source>Diabetes</source>
<volume>52</volume>
<fpage>1888</fpage>
<lpage>1896</lpage>
<pub-id pub-id-type="pmid">12882902</pub-id></element-citation></ref><ref id="pmed-0040076-b059"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hood</surname><given-names>DA</given-names></name></person-group>
<year>2001</year>
<article-title>Invited Review: Contractile activity-induced mitochondrial biogenesis in skeletal muscle</article-title>
<source>J Appl Physiol</source>
<volume>90</volume>
<fpage>1137</fpage>
<lpage>1157</lpage>
<pub-id pub-id-type="pmid">11181630</pub-id></element-citation></ref><ref id="pmed-0040076-b060"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Russell</surname><given-names>AP</given-names></name><name><surname>Feilchenfeldt</surname><given-names>J</given-names></name><name><surname>Schreiber</surname><given-names>S</given-names></name><name><surname>Praz</surname><given-names>M</given-names></name><name><surname>Crettenand</surname><given-names>A</given-names></name><etal></etal></person-group>
<year>2003</year>
<article-title>Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle</article-title>
<source>Diabetes</source>
<volume>52</volume>
<fpage>2874</fpage>
<lpage>2881</lpage>
<pub-id pub-id-type="pmid">14633846</pub-id></element-citation></ref><ref id="pmed-0040076-b061"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nisoli</surname><given-names>E</given-names></name><name><surname>Carruba</surname><given-names>MO</given-names></name></person-group>
<year>2006</year>
<article-title>Nitric oxide and mitochondrial biogenesis</article-title>
<source>J Cell Sci</source>
<volume>119</volume>
<fpage>2855</fpage>
<lpage>2862</lpage>
<pub-id pub-id-type="pmid">16825426</pub-id></element-citation></ref><ref id="pmed-0040076-b062"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Navarro</surname><given-names>A</given-names></name><name><surname>Torrejon</surname><given-names>R</given-names></name><name><surname>Bandez</surname><given-names>MJ</given-names></name><name><surname>Lopez-Cepero</surname><given-names>JM</given-names></name><name><surname>Boveris</surname><given-names>A</given-names></name></person-group>
<year>2005</year>
<article-title>Mitochondrial function and mitochondria-induced apoptosis in an overstimulated rat ovarian cycle</article-title>
<source>Am J Physiol Endocrinol Metab</source>
<volume>289</volume>
<fpage>E1101</fpage>
<lpage>1109</lpage>
<pub-id pub-id-type="pmid">16014352</pub-id></element-citation></ref><ref id="pmed-0040076-b063"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>GC</given-names></name><name><surname>Cooper</surname><given-names>CE</given-names></name></person-group>
<year>1994</year>
<article-title>Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase</article-title>
<source>FEBS Lett</source>
<volume>356</volume>
<fpage>295</fpage>
<lpage>298</lpage>
<pub-id pub-id-type="pmid">7805858</pub-id></element-citation></ref><ref id="pmed-0040076-b064"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poderoso</surname><given-names>JJ</given-names></name><name><surname>Carreras</surname><given-names>MC</given-names></name><name><surname>Lisdero</surname><given-names>C</given-names></name><name><surname>Riobo</surname><given-names>N</given-names></name><name><surname>Schopfer</surname><given-names>F</given-names></name><etal></etal></person-group>
<year>1996</year>
<article-title>Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles</article-title>
<source>Arch Biochem Biophys</source>
<volume>328</volume>
<fpage>85</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="pmid">8638942</pub-id></element-citation></ref><ref id="pmed-0040076-b065"><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Valdez</surname><given-names>LB</given-names></name><name><surname>Zaobornyj</surname><given-names>T</given-names></name><name><surname>Boveris</surname><given-names>A</given-names></name></person-group>
<year>2006</year>
<article-title>Mitochondrial metabolic states and membrane potential modulate mtNOS activity</article-title>
<source>Biochim Biophys Acta</source>
<volume>1757</volume>
<fpage>166</fpage>
<lpage>172</lpage>
<pub-id pub-id-type="pmid">16624252</pub-id></element-citation></ref></ref-list></back></article>